US20050096717A1 - Apparatus and method for coupling therapeutic and/or monitoring equipment to a patient - Google Patents

Apparatus and method for coupling therapeutic and/or monitoring equipment to a patient Download PDF

Info

Publication number
US20050096717A1
US20050096717A1 US10/994,372 US99437204A US2005096717A1 US 20050096717 A1 US20050096717 A1 US 20050096717A1 US 99437204 A US99437204 A US 99437204A US 2005096717 A1 US2005096717 A1 US 2005096717A1
Authority
US
United States
Prior art keywords
coupler
support member
recipient
coupling
engagement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/994,372
Inventor
Jon Bishay
Paul Leonard
Jay Miazga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meagan Medical Inc
Original Assignee
Meagan Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/452,477 external-priority patent/US6622051B1/en
Priority claimed from US09/666,931 external-priority patent/US6529776B1/en
Application filed by Meagan Medical Inc filed Critical Meagan Medical Inc
Priority to US10/994,372 priority Critical patent/US20050096717A1/en
Assigned to MEAGAN MEDICAL, INC. reassignment MEAGAN MEDICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: VERTIS NEUROSCIENCE, INC.
Publication of US20050096717A1 publication Critical patent/US20050096717A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551Spinal or peripheral nerve electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0502Skin piercing electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36021External stimulators, e.g. with patch electrodes for treatment of pain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36017External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin

Definitions

  • This invention relates generally to apparatuses and methods for coupling therapeutic and/or monitoring equipment to a patient.
  • transcutaneous electrical nerve stimulation systems deliver electrical energy through electrode patches placed on the surface of a patient's skin to treat pain in tissue beneath and around the location of the patches.
  • TENS transcutaneous electrical nerve stimulation
  • the TENS systems may not adequately alleviate pain in certain circumstances.
  • PNT Percutaneous Neuromodulation Therapy
  • PNS Percutaneous Electrical Nerve Stimulation
  • PNT percutaneous Electrical Nerve Stimulation
  • PNS Percutaneous Electrical Nerve Stimulation
  • This therapy is described in Ghoname et al., “Percutaneous Electrical Nerve Stimulation for Low Back Pain,” JAMA 281:818-23 (1999); Ghoname et al., “The Effect of Stimulus Frequency on the Analgesic Response to Percutaneous Electrical Nerve Stimulation in Patients with Chronic Low Back Pain,” Anesth. Analg.
  • PNT practitioners have used percutaneously placed acupuncture needles attached to waveform generators via cables and alligator clips to deliver the therapy to the patient.
  • One feature of conventional PNT systems is that they typically include a number of electrical cables that must be properly connected to the corresponding percutaneous electrodes to deliver effective electrical therapy. Accordingly, a drawback with these conventional systems is that it can be difficult (particularly for inexperienced practitioners) to connect each electrical cable to the proper corresponding electrode. This drawback is shared as well by other systems that require multiple connections to the patient. Such systems include electrical monitoring systems and drug delivery systems.
  • An apparatus in accordance with one aspect of the invention can include a support member configured to rest on a body of the recipient proximate to a coupling region.
  • the support member can include a first coupler location configured to removably carry a first coupler proximate to a first coupling position of the body of the recipient.
  • the support member can further include a second coupler location configured to removably carry a second coupler proximate to a second coupling position of the body of the recipient.
  • the support member can be spaced apart from the first and second coupling positions.
  • the support member can be elongated along a support member axis and the first coupler location can be positioned closer than the second coupler location to the support member axis.
  • the first coupler location can be positioned closer than the second coupler location to the first coupling position. Accordingly, the apparatus can guide a practitioner to connect the couplers to the correct coupling position.
  • the support member can be flexible and resilient to conform to a surface of the body, and can be shaped to rest on at least one of a back, a neck, a head, and a leg of the recipient.
  • the apparatus can further include a flexible link coupled between the first coupler and the support member.
  • the link can remain connected between the first coupler and the support member when the first coupler is moved from an attached position to a detached position and then to a coupled position with the coupler coupled to the body of the recipient.
  • the link can include an electrical cable configured to be coupled to a source of electrical pulses, an electrical cable configured to be coupled to a signal monitor, and/or a length of tubing configured to be coupled to a source of liquid medicament.
  • the first and second coupling positions can be two of a larger plurality of coupling positions and the first and second coupler locations can be two of a larger plurality of coupler locations.
  • An outline of the coupling positions can define a first shape and an outline of the coupler locations can define a corresponding second shape at least generally similar to the first shape.
  • the invention is also directed toward a method for coupling therapy and/or monitoring equipment to a recipient.
  • the method can include positioning a support member against a body of a recipient proximate to a coupling area, supporting a first coupler relative to the body at a first coupler location of the support member proximate to a first coupling position of the body, and supporting a second coupler relative to the body at a second coupler location of the support member proximate to a second coupling position of the body.
  • the support member can be elongated along a support member axis and the first coupler location can be positioned closer than the second coupler location to the first coupling position and/or to the support member axis.
  • the support member can be spaced apart from the first and second coupling positions.
  • the method can further include removing the first coupler from the support member and coupling the first coupler to the body at the first coupling position, and removing the second coupler from the support member and coupling the second coupler to the body at the second coupling position.
  • FIG. 1A -G are schematic renderings of a percutaneous electrical therapy system according to one embodiment of this invention.
  • FIG. 1A shows electrode and angle of insertion assemblies wherein the electrode is in an undeployed and uninserted state.
  • FIG. 1B shows the electrode and angle of insertion assemblies of FIG. 1A during deployment but prior to insertion of the electrode into a patient's tissue.
  • FIG. 1C shows the electrode and angle of insertion assemblies of FIG. 1A during deployment and insertion of the electrode into the patient's tissue.
  • FIG. 1D shows the electrode of FIG. 1A inserted into the patient's tissue.
  • FIG. 1E shows the electrode of FIG. 1A attached to a control unit to provide percutaneous electrical therapy.
  • FIG. 1F shows the electrode and angle of insertion assemblies of FIG. 1A during undeployment but prior to removing the electrode from the patient's tissue.
  • FIG. 1G shows the electrode and sharp point protection assemblies of FIG. 1A during undeployment and after removing the electrode from the patient's tissue.
  • FIGS. 2 A-E are schematic renderings of a percutaneous electrical therapy system according to another embodiment of this invention.
  • FIG. 2A shows a percutaneous electrical therapy system with electrode and angle of insertion assemblies wherein the electrode is in an undeployed and uninserted state.
  • FIG. 2B shows the percutaneous electrical therapy system of FIG. 2A during deployment, but prior to insertion, of the electrode.
  • FIG. 2C shows the percutaneous electrical therapy system of FIG. 2A with the electrode in a deployed and inserted state.
  • FIG. 2D shows the percutaneous electrical therapy system of FIG. 2A during undeployment of the electrode.
  • FIG. 2E shows the percutaneous electrical therapy system of FIG. 2A after the electrode has been undeployed.
  • FIG. 3 shows an electrode montage for use in percutaneous neuromodulation therapy to treat low back pain.
  • FIG. 4 is an exploded sectional view of an electrode and angle of insertion assembly according to yet another embodiment of this invention.
  • FIG. 5 is a partially exploded elevational view of the embodiment of FIG. 4 .
  • FIG. 6 is an elevational view of the embodiment of FIG. 4 showing the electrode and angle of insertion assemblies and a coupler.
  • FIG. 7 is a sectional view of the embodiment of FIG. 4 showing the electrode and angle of insertion assemblies and a coupler.
  • FIG. 8 is a sectional view of the embodiment of FIG. 4 showing the coupler in engagement with the electrode and angle of insertion assemblies prior to insertion of the electrode into a patient's tissue.
  • FIG. 9 is a sectional view of the embodiment of FIG. 4 with the electrode in its deployed and inserted state.
  • FIG. 10 shows a montage for using the embodiment of FIG. 4 to treat low back pain with the electrodes in a partially deployed but uninserted state.
  • FIG. 11 shows the electrode montage of FIG. 10 at the beginning of the electrode insertion step.
  • FIG. 12 shows the electrode montage of FIG. 10 with the electrodes deployed, inserted and attached to a control unit to provide electrical therapy to the patient.
  • FIG. 13 is an exploded view of an electrode introducer and angle of insertion assembly of yet another embodiment of this invention.
  • FIG. 14 is a partial sectional view of the introducer and angle of insertion assembly of FIG. 13 .
  • FIG. 15 is a sectional view of the introducer and angle of insertion assembly of FIG. 13 .
  • FIG. 16 is an elevational view of gear assemblies of the introducer and angle of insertion assembly of FIG. 13 .
  • FIG. 17 shows part of the electrode assembly of the embodiment of FIGS. 13-16 in a montage used for treating low back pain using PNT.
  • FIG. 18 is an elevational view showing the introducer of FIG. 13 in the process of deploying an electrode.
  • FIG. 19 is a sectional view showing the introducer of FIG. 13 in the process of deploying an electrode, prior to insertion of the electrode.
  • FIG. 20 is a sectional view showing the introducer of FIG. 13 in the process of deploying an electrode, during insertion of the electrode.
  • FIG. 21 is a sectional view showing the introducer of FIG. 13 in the process of deploying an electrode, also during insertion of the electrode.
  • FIG. 22 is a sectional view of an inserted electrode assembly of the embodiment of FIGS. 13-16 .
  • FIG. 23 is a partially schematic, top isometric view of a coupler support in accordance with an embodiment of the invention.
  • FIG. 24 is a partially schematic, top isometric view of a coupler support positioned on the back of a recipient in accordance with another embodiment of the invention.
  • FIG. 25 is a partially schematic, top plan view of a support member positioned near coupling positions in accordance with another embodiment of the invention.
  • FIG. 26 is a top isometric view of a portion of a coupler support configured to support a coupler in accordance with another embodiment of the invention.
  • FIG. 27 is a top isometric view of a portion of a coupler support having an aperture configured to receive a clamp-type coupler in accordance with still another embodiment of the invention.
  • FIG. 28 is a top isometric view of a portion of a coupler support having a post configured to be clamped by a clamp-type coupler in accordance with yet another embodiment of the invention.
  • FIG. 29 is a partially schematic illustration of an arrangement that includes a coupler support configured to support couplers for receiving diagnostic information in accordance with yet another embodiment of the invention.
  • FIG. 30 is a partially schematic illustration of an arrangement that includes a coupler support configured to support a plurality of couplers that administer liquid medicament in accordance with still another embodiment of the invention.
  • Percutaneous electrical therapy systems such as PNT systems, deliver electric current to a region of a patient's tissue through electrodes that pierce the skin covering the tissue.
  • the electric current is generated by a control unit external to the patient and typically has particular waveform characteristics such as frequency, amplitude and pulse width.
  • a control unit external to the patient and typically has particular waveform characteristics such as frequency, amplitude and pulse width.
  • the electrode has a sharp point not only to facilitate insertion through the patient's skin but also to enhance local current density during treatment. The placement and location of the electrode point is therefore an important aspect of the therapy.
  • the electrodes must also be properly coupled to the control unit to form a complete circuit for delivering therapeutic electric current to the patient.
  • FIGS. 1 A-G are block diagrams showing deployment and use of a percutaneous electrical therapy system and electrode assembly in accordance with an embodiment of the invention.
  • the system can include an electrode 1 having a sharp point 2 at its distal end and a housing 4 surrounding at least the sharp point 2 when the electrode is in its undeployed and uninserted states.
  • the undeployed and uninserted states include pre-deployment and post-deployment states of the electrode 1 .
  • the housing 4 can have an aperture 5 at its distal end.
  • An actuator 6 can interact with a handle 11 at the proximal end of electrode 2 as shown to move the electrode 1 .
  • FIG. 1A shows the electrode assembly in an undeployed (pre-deployed) state.
  • the distal face 7 of housing 4 is placed against a patient's skin 22 , as shown in FIG. 1B .
  • This action supports housing 4 with respect to the patient's skin, thereby controlling the angle between the housing and the patient's skin.
  • Electrode 2 is then inserted through aperture 5 into the tissue underlying the patient's skin by moving actuator 6 distally, as shown in FIG. 1C . As it moves, actuator 6 (and therefore electrode 2 ) is supported by housing 4 to control the angle at which the electrode 1 enters into the patient's tissue.
  • the actuator 6 may have a limit stop 9 element cooperating with a limit stop area 8 of the housing 4 to limit distal motion of the actuator 6 and to control the depth of insertion of the sharp point 2 of the electrode 1 .
  • the predetermined electrode depth is 3 cm. Other electrode depths may be used, of course, depending on the intended application and therapy.
  • the electrode 1 can be connected to a control unit 10 via a conductor or cable 16 .
  • the control unit 10 can supply a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, a frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 ⁇ sec and 1 msec.
  • Other electrical waveforms having other parameters may be used, of course, depending on the therapy to be provided.
  • FIG. 1E shows only one electrode connected to the control unit, it should be understood that a plurality of electrodes may be connected to a single control unit.
  • the electrode assembly can be undeployed.
  • the aperture 5 of housing 4 is placed over the handle portion 11 of electrode 1 .
  • Housing 4 may be the same housing used to deploy and insert the electrode (i.e., the electrode introducer), or it may be an entirely different assembly (e.g., an electrode remover).
  • the sharp point 2 of electrode 1 is then drawn into housing 4 of sharp point protection assembly 3 by moving actuator 6 proximally, as shown in FIG. 1G .
  • FIGS. 2 A-E are block diagrams showing another embodiment of the invention.
  • a control unit 10 is connected to an electrode 12 within an electrode assembly 13 via a conductor 16 .
  • the control unit 10 can supply a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, a frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 ⁇ sec and 1 msec.
  • the control unit 10 can supply electrical current having other characteristics.
  • the system can include a housing 18 surrounding the sharp point 20 of electrode 12 when the electrode point 20 has not yet been inserted through the patient's skin 22 .
  • a distal face 21 of the housing 18 is placed against the patient's skin 22 , as shown in FIG. 2B .
  • this action supports the housing 18 with respect to the patient's skin, thereby controlling the angle between the housing and the patient's skin.
  • the sharp point 20 of electrode 12 is then inserted through an aperture 24 into the tissue underlying the patient's skin by moving an actuator 19 distally, as shown in FIG. 2C .
  • the actuator 19 (and therefore the electrode 12 ) is supported by the housing 18 to control the angle at which the electrode enters into the patient's tissue.
  • the actuator 19 may be part of the electrode assembly 13 or a separate component of the system.
  • the actuator 19 may also have a limit stop element 23 that cooperates with a limit stop area 17 of housing 18 to limit distal movement of actuator 19 , thereby controlling the depth of insertion of electrode 12 .
  • the predetermined electrode depth is approximately 3 cm, although other electrode depths may be used depending on the application.
  • the control unit 10 may then provide the appropriate therapy to the patient through the electrode 12 and any other electrodes connected to it.
  • the actuator 19 can draw the electrode 12 back proximally into the housing 18 .
  • the housing 18 of sharp point protection assembly 14 once again surrounds the sharp point 20 of the now uninserted electrode 12 , as shown in FIGS. 2D and 2E .
  • the actuator 19 helps enable this operation to occur without ever exposing the sharp point 20 of the electrode 12 when the sharp point 20 is no longer in the patient. In fact, the operator of the electrode assembly never sees the sharp point 20 of the electrode 12 .
  • sharp point protection assembly 14 shields the potentially contaminated portion of the undeployed electrode 12 and protects the patient's caregiver or other bystander from unintended contact with the sharp point 20 of the electrode 12 before, during and after electrical therapy.
  • FIGS. 2 A-E show the electrode connected to the control unit prior to deployment and insertion of the electrode into the patient's skin, the connection between the control unit and the electrode could be made during deployment or after insertion. Also, while FIGS. 2 A-E show only one electrode connected to the control unit, it should be understood that a plurality of electrodes may be connected to a single control unit, as called for by the desired electrical stimulation treatment.
  • one or more electrodes are inserted through the patient's skin into the underlying tissue.
  • an array or montage such as that shown in FIG. 3 may be used.
  • the “T 12 ”-“S 1 ” designations refer to the patient's vertebrae.
  • the control unit or generator supplies current pulses between pairs of electrodes for durations of a few minutes to several hours, preferably delivering the current-regulated waveform described above. Thirty-minute treatments are recommended in the Ghoname et al. low back pain treatment articles.
  • FIGS. 4-12 show a system in accordance with another embodiment of this invention.
  • An electrode assembly 30 can include a base 32 , an electrode 34 , and a plunger or actuator 36 .
  • the base 32 can have a flange or flared end 44 that is adapted to make contact with a patient's skin.
  • the base 32 may be formed from any suitable polymer or metal, such as a high-density polyethylene (HDPE).
  • the base 32 can be opaque so that the electrode 34 cannot be seen by a needle-shy patient.
  • the actuator 36 fits within a housing portion 40 of base 32 in a slidable arrangement.
  • a locking assembly can prevent relative movement between the actuator 36 and the housing 40 of the base 32 .
  • the locking assembly of the actuator 36 has integrally-formed resilient detents 48 on its exterior cylindrical surface. In the undeployed state of electrode assembly 30 , the detents 48 mate with corresponding openings 50 in the base 32 to hold the actuator 36 and the base 32 in place with respect to each other to prevent the electrode 34 from moving outside of the protective housing 40 of the base 32 , thereby providing sharp point protection.
  • mechanisms other than the detent and opening arrangement may be used to hold the actuator and base in place.
  • the electrode 34 can include a 3-cm long 32-gauge stainless steel needle. Other sizes and materials may be used for the electrode 34 , of course, without departing from the scope of the invention.
  • the actuator 36 can be formed from HDPE as well, although other suitable materials may be used.
  • the electrode 34 can have a larger-diameter handle 52 at its proximal end.
  • the handle 52 can fit within a channel 54 formed within the actuator 36 .
  • the channel 54 can have a narrow opening 56 at its distal end, with a diameter slightly larger than the diameter of electrode 34 but narrower than the diameter of handle 52 to hold electrode 34 in place within the actuator 36 after initial manufacture and assembly.
  • the sharp point 38 of electrode 34 is disposed within housing portion 40 of base 32 , specifically, within a narrow channel 42 of the housing 40 .
  • the distal surface 46 of the flange portion 44 of the base 32 can be mounted on the desired site on the patient's skin, preferably with a compressible adhesive pad (not shown) surrounding a ring 43 extending downward from surface 46 around an aperture 41 formed at the distal end of channel 42 , although other means of attaching base 32 to the patient may be used as appropriate. This action aligns the base 32 with respect to the patient's skin.
  • the flange portion 44 of the base 32 provides extra stability for the electrode assembly during electrode insertion and use.
  • a coupler or actuator tool 60 can be used to both insert the electrode and connect the electrode electrically with a control unit 62 .
  • the coupler 60 and the electrode assembly 30 can also interact to provide the sharp point protection assembly of this embodiment.
  • the exposed proximal end 64 of the electrode handle 52 makes electrical contact with a contact surface 66 within the coupler 60 .
  • the contact surface 66 in turn, can be electrically connected to the control unit 62 via a cable or other conductor 68 .
  • the coupler 60 can have two oppositely disposed pegs 70 extending outwardly from the distal portion of its cylindrically surface.
  • the pegs 70 can mate with two corresponding slots 72 in the actuator 36 and with two corresponding grooves 74 in the base 32 .
  • the second of the two slots 72 and the second of the two grooves 74 are each opposite the slot 72 and groove 74 , respectively, shown in FIGS. 4 and 5 .
  • the pegs 70 move along longitudinal portions 76 of the slots 72 and along longitudinal portions 78 of the grooves 74 .
  • the exposed distal end 64 of the electrode handle 52 begins to make sliding contact with the contact surface 66 of actuator tool 60 to create the electrical connection between coupler 60 and the electrode 32 .
  • the coupler 60 can be rotated clockwise (looking down on the assembly), after the pegs 70 reach the end of the longitudinal portions 76 and 78 . Accordingly, the pegs 70 move into short circumferential portions 80 and 82 , respectively, of the slots 72 and the grooves 74 .
  • the length of the circumferential portions 80 of the slots 72 is less than the length of the circumferential portions 82 of the grooves 74 .
  • Continued movement of the pegs 70 along the circumferential portions 82 will therefore move the pegs 70 against the ends 81 of the circumferential slots 80 .
  • Further clockwise rotation of the coupler 60 will cause the actuator 36 to rotate clockwise as well, thereby moving the detents 48 out of the openings 50 and allowing the electrode 34 and the actuator 36 to move with respect to base 32 .
  • Second longitudinal portions 84 of the grooves 74 can be formed in base 32 at the end of circumferential portions 82 . Movement of the pegs 70 distally along the second longitudinal portions 84 pushes the pegs 70 against the distal edges of the circumferential slot portions 80 , thereby moving the actuator 36 and the electrode 34 in a controlled fashion distally toward the patient's skin 22 .
  • the electrode 34 passes through the channel 42 , and the sharp point of electrode 34 moves out through aperture 41 .
  • the channel 42 and the actuator 36 provide axial support to the electrode 34 during this forward movement and also, along with the support provided by the flange 44 , provide entry angle guidance to the electrode 34 .
  • downward pressure on the patient's skin during electrode deployment can compress the compressible adhesive pad and press the ring 43 against the patient's skin 22 , which helps ease electrode entry through the skin and also lessens the insertion pain experienced by the patient.
  • the alignment of the base 32 with respect to the patient's skin and the controlled movement of the actuator 36 and the electrode 34 within the base 32 can control the angle at which the electrode enters the tissue underlying the patient's skin. Distal movement of the electrode 34 and its actuator within the base 32 can continue until a distal surface 86 of a cylindrical cap portion 92 of the coupler 60 meets an annular surface 88 of housing 40 . At this point, the sharp point 38 of the electrode 34 has extended a predetermined depth into the tissue underlying the patient's skin. In one embodiment, this predetermined depth is approximately 3 cm, and the depth can have other values depending on the treatment to be performed.
  • the electrode assembly 30 can also include a deployed electrode holding mechanism.
  • a deployed electrode holding mechanism In one aspect of this embodiment, an interference fit between the inner surface of channel 42 and the outer surface 55 of channel 52 performs this function.
  • the control unit 62 can supply stimulation current to the electrodes, e.g., in the manner described in the Ghoname et al. articles.
  • the electrical waveform provided by the control unit depends on the application.
  • the control unit 62 can provide a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 ⁇ sec and 1 msec.
  • the control unit 62 can provide electrical current at other frequencies.
  • the interaction of the coupler 60 and the base 32 can provide stability to the electrode 34 and its electrical connection to the control unit during treatment by holding the electrode in place, by providing strain relief for tugging forces on the cable 68 , and by providing a robust mechanical connection. It should also be noted that in one aspect of these embodiments, the sharp point of the electrode 34 is not exposed to the operator or to any other bystander at any point during deployment and use of the electrode assembly.
  • the electrode may be removed from the patient.
  • the coupler 60 can be moved proximally away from the patient.
  • the pegs 70 move proximally along the longitudinal portions 84 of the grooves 74 , the pegs 70 push against the proximal edges of the actuator's circumferential slot portions 80 , thereby moving the actuator 36 and the electrode 34 proximally as well.
  • the sharp end 38 of the electrode 34 is out of the patient and safely inside the housing 40 of the base 32 .
  • Counterclockwise movement of the coupler 60 moves the pegs 70 along the circumferential portions 80 and 82 of the slot 72 and the groove 74 , respectively. Because the circumferential portion 80 is shorter than the circumferential portion 82 , this counterclockwise movement will turn the actuator 36 counterclockwise.
  • the detents 48 move back into the openings 50 to prevent further movement of the electrode and the actuator with respect to the base 32 .
  • Further distal movement of the coupler 60 moves the pegs 70 distally along the longitudinal portions 76 and 78 of the slot 72 and the groove 74 , respectively, to disconnect the coupler 60 from the electrode assembly 30 .
  • the base 32 can then be removed from the patient.
  • FIGS. 10-12 show the use of the electrode and sharp point protection assemblies of FIGS. 4-9 to treat low back pain using PNT.
  • ten electrode assemblies 30 a - j are arranged in a montage on the patient's back and attached with adhesive.
  • ten couplers 60 a - j are attached to the ten electrode assemblies 30 a - j .
  • the couplers 60 a - j are supported or carried prior to deployment by a coupler support 61 ( FIG. 12 ).
  • the coupler support 61 can include a generally flat, rigid support member 63 having ten engagement members 65 positioned at corresponding coupler locations of the support member 63 .
  • Each engagement member 65 can be configured to removably support or carry one of the couplers 60 .
  • each engagement member 65 can include a post projecting upwardly from the support member 63 to be removably received in a corresponding axial aperture of the coupler 60 .
  • each coupler 60 can be connected to the support member 63 with an individual cable 68 a - j .
  • the individual cables 68 a - j can be bundled together to form a link 69 (such as a multi-wire cable) that provides electrical communication between the couplers 60 and a control unit 62 .
  • an arrangement of the engagement members 65 on the support member 63 can correspond to an arrangement of the electrode assemblies 30 a - j on the patient's back.
  • the engagement members 65 can be arranged in two rows, one on each side of a central axis 67 ( FIG. 11 ) that can be aligned with the patient's spine. Accordingly, the arrangement of the engagement members 65 can guide the practitioner to connect each coupler 60 to the proper electrode assembly 30 .
  • each electrode assembly 30 is paired with another to define a complete electrical circuit (with one electrode serving as an anode and an adjacent electrode serving as a cathode), it can be important to correctly match the individual cable 68 with the corresponding electrode assembly. For example, if a given electrode assembly 30 serving as an anode is inadvertently placed too distant from the corresponding electrode assembly 30 serving as a cathode, the current applied to the electrode assemblies may be too weak to be effective. Furthermore, when the characteristics of the electrical signals supplied to each circuit are controlled separately, it may not be clear which circuit is being controlled if the couplers 60 are attached to the wrong electrode assemblies.
  • the coupler support 61 can increase the effectiveness of the electrical stimulation therapy by reducing the likelihood that the couplers 60 will be incorrectly deployed.
  • the coupler support 61 can have other configurations and can support couplers having other configurations, as described below with reference to FIGS. 23-30 .
  • the control unit 62 provides electrical signals to treat the patient.
  • half the electrodes e.g., assemblies 30 b , 30 d , 30 g , 30 h and 30 i
  • the control unit 62 can provide a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 ⁇ sec and 1 msec. to treat the patient's low back pain using PNT.
  • FIGS. 13-22 illustrate an apparatus in accordance with another embodiment of the invention.
  • an electrode introducer and an alignment member mounted on the patient's skin provide an electrode angle of insertion assembly controlling the electrode's angle of entry into the patient's tissue.
  • an electrode introducer 100 shown in FIGS. 13-16 and 19 - 21 can insert multiple electrodes. It should be understood that the principles of this invention could be applied to an introducer designed to hold and insert any number of electrodes.
  • Twelve electrodes 102 are disposed within a magazine 103 rotatably mounted within a housing 104 .
  • the housing 104 is a two-part injection molded polystyrene assembly.
  • the magazine 103 rotates about a hub 105 mounted on supports formed in housing 104 .
  • a leaf spring 106 mates with one of twelve radial grooves 108 formed in the magazine 103 to form a twelve-position ratchet mechanism for the rotatable magazine 103 in the housing 104 .
  • the magazine 103 can have twelve electrode chambers 115 arranged radially about the hub 105 .
  • each chamber 115 contains one electrode 102 .
  • the diameter of an upper portion 118 of the chamber 115 is sized to form an interference fit with the wider portions 112 and 114 of electrode handle portion 107 of electrode 102 .
  • a lower wide portion 114 of electrode 102 can be formed from a compressible material.
  • the diameter of a lower portion 119 of the chamber 115 is slightly larger so that there is no interference fit between the lower portion 119 and the electrode handle 107 , for reasons explained below.
  • the opening 106 of a magazine chamber 115 is lined up with the aperture 117 of the introducer 100 , as shown in FIGS. 14 and 15 .
  • a slide member 109 is disposed on a rail 110 formed in the housing 104 . Extending longitudinally downwardly from the slide member 109 is a drive rod 111 , and extending longitudinally upwardly from the slide member 109 is a gear rack 120 .
  • the teeth of the gear rack 120 cooperate with the teeth on a rotational gear 122 mounted about a shaft 124 extending into a shaft mount 126 formed in the housing 104 .
  • a second set of teeth are mounted on a smaller diameter rotational gear 128 (shown more clearly in FIG. 16 ) which is also mounted about the shaft 124 .
  • the gears 122 and 128 rotate together about the shaft 124 .
  • the teeth of the smaller diameter gear 128 mesh with the teeth of a second gear rack 130 extending from a longitudinally-movable actuator 132 .
  • a flexible and compressible annular patch 140 is placed on the patient's skin at the desired site, preferably with an adhesive (not shown).
  • an adhesive for example, to treat low back pain using PNT, the arrangement or montage shown in FIG. 17 may be used. In this montage, five electrodes serve as cathodes and five serve as anodes.
  • the patch 140 has an annular rigid member 141 disposed in its center and extending upwardly from it.
  • the rigid member 141 has a smaller diameter opening 142 leading to a larger diameter opening 144 .
  • the diameter of the opening 142 is slightly smaller than the lower wide portion 114 of the handle portion 107 of the electrode 102 and slightly larger than the diameter of the central portion 113 of handle portion 107 of the electrode 102 .
  • the distal end of the introducer 100 is placed against the patch 140 so that the introducer aperture 117 surrounds the upwardly extending portion of rigid patch member 141 , as shown in FIG. 18 .
  • This interaction aligns the opening 116 of one of the introducer's magazine chambers 115 with the opening 142 of the rigid member 141 and helps control the electrode's angle of entry, as shown in FIG. 19 .
  • Downward pressure on the introducer 100 compresses the patch 140 , thereby causing the upper surface of the rigid member 141 to engage a lower surface of the magazine 103 , and pressing the rigid member 141 downward into the patient's skin 22 .
  • This pressure on the patient's skin around the insertion site can reduce the pain caused by inserting the electrode.
  • Depressing the actuator 132 moves the gear rack 130 distally, which causes the gears 128 and 122 to rotate. Because the diameter and tooth count of the gear 128 differ from the diameter and tooth count the gear 122 , the gear rack 120 moves longitudinally a much greater distance than the corresponding longitudinal movement of the gear rack 130 . This feature enables the electrode to be inserted its required distance into the patient's skin using only a comparatively small movement of the operator's thumb. Distal movement of the gear rack 120 is guided by the movement of the slide member 109 along the rail 110 .
  • the drive rod 111 moves into a magazine chamber 115 until the distal end of the drive rod 111 engages the top surface of the electrode's handle portion 107 . As shown in FIG. 20 , further distal movement of the drive rod 111 pushes the electrode 102 downwardly so that the sharp point 108 of the electrode 102 leaves the introducer housing and enters the patient's skin 22 and the tissue beneath the skin.
  • the chamber 115 provides axial stability to the electrode 102 during insertion.
  • the actuator 132 and the drive rod 111 pushes the lower larger diameter portion 114 of the electrode handle 107 through the smaller diameter portion 142 of rigid member 141 by compressing the handle portion 114 . Further downward movement pushes the handle portion 114 into the larger diameter portion 144 of the rigid member 141 so that the rigid member's smaller diameter portion lies between the larger diameter portions 112 and 114 of the electrode handle 107 .
  • This interaction holds the electrode in place in the patient's tissue and helps provide depth control for electrode insertion.
  • the preferred depth of the electrode's sharp point 108 is approximately 3 cm, although the electrode may be inserted to other depths depending on the treatment to be performed.
  • the slider member 109 also acts as a limit stop at this point when it engages the limit stop area 145 of housing 104 , thereby also controlling electrode insertion depth.
  • the magazine 103 can be rotated to a new insertion position and placed against an empty patch 140 after insertion of each electrode until all electrodes have been deployed and inserted.
  • a suitable electrical connector 148 such as an alligator clip, can be electrically connected to electrode 102 through an aperture (not shown) formed in the upper larger diameter portion 112 of electrode handle 107 to provide electrical communication between a control unit 150 and electrode 102 via a cable or other conductor 149 , as shown in FIG. 22 .
  • the patch 140 can provide strain relief for the electrode 102 by preventing tugging forces on the cable 149 from dislodging the electrode from the patient, thereby helping keep the electrode in place.
  • the sharp point of the electrode is not exposed to the operator or bystander at any point during the electrode deployment, insertion and electrical therapy treatment processes.
  • the control unit 150 supplies stimulation current to the electrodes, e.g., in the manner described in the Ghoname et al. articles.
  • the electrical waveform provided by the control unit depends on the application.
  • the control unit 150 can provide a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 ⁇ sec and 1 msec.
  • the lower wide portion of the electrode handle can be formed from a rigid material and can have rounded camming edges.
  • the central annulus of patch 140 in this alternative embodiment is either compressible or has a resilient camming opening under the camming action of the electrode handle.
  • FIG. 23 is a top isometric view of a coupler support 200 that supports or carries couplers 260 in accordance with another embodiment of the invention.
  • the coupler support 200 includes a support member 220 and ten engagement members 240 positioned at coupler locations of the support member 220 . Each engagement member 240 can removably support one of the couplers 260 .
  • the couplers 260 can be generally similar to the coupler 60 described above with reference to FIGS. 4-12 .
  • the coupler 260 can have other configurations, such as the configuration disclosed in co-pending U.S. application Ser. No. 09/666,931, entitled “Method and Apparatus for Repositioning a Percutaneous Probe,” incorporated above by reference.
  • the coupler can have other configurations, for example, those described below with reference to FIGS. 27-30 .
  • each engagement member 240 can have columnar or post shape and can be removably received in a downward facing aperture of the coupler 260 .
  • the engagement member 240 can extend a sufficient distance upwardly into the aperture of the coupler 260 to firmly support the coupler 260 relative to the support member 220 .
  • the engagement member 240 can have other configurations (for example, when the coupler has other configurations), as described below with reference to FIGS. 26-30 .
  • the coupler support 200 can include links 250 between the support member 220 and each coupler 260 .
  • the links 250 can include electrical cables to transmit electrical signals to the couplers 260 and to the patient or recipient to whom the couplers 260 are attached.
  • the links 250 can have other configurations, as described below with reference to FIGS. 27-30 .
  • different links 250 can have different lengths to allow the corresponding coupler 260 to be coupled to the appropriate site on the recipient.
  • each link 250 can have the same length, so long as the length is sufficient for each coupler 260 to be coupled to the proper site on the recipient.
  • a single support member 220 with a single set of links 250 can be compatible with recipients ranging in height from about 4.5 feet to about 6.5 feet.
  • each link 250 can enter the support member 220 at an entry attachment point 223 .
  • the links 250 can then pass through a cable channel 212 of the support member 220 and exit the support member 220 at an exit attachment point 224 .
  • the links 250 can be bundled together to form a bundled link 251 that can be attached to an electrical connector 252 for coupling to a source of electrical potential.
  • the support member 220 can include an upper portion 210 bonded to a lower portion 211 .
  • the upper portion 210 can include the cable channel 212 and the engagement members 240 .
  • the support member 220 can be formed by molding the upper portion 210 , inverting the upper portion 210 , and laying a cable harness (which includes the bundled link 251 and the individual links 250 ) into the cable channel 212 .
  • the lower portion 211 can be attached to the upper portion 210 (for example, in an overmold process) to fix the harness into the support member 220 .
  • the coupler support 200 can be formed with other techniques.
  • the support member 220 can include a flexible, soft durometer, bio-compatible, thermoplastic elastomeric material, such as Sanoprene®, available from Advanced Elastomeric Systems of Akron, Ohio. Accordingly, the support member 220 can conform to the shape of the recipient's body, as described below with reference to FIG. 24 .
  • the shape of the support member 220 and the positions of the engaging members on the support member 220 can be configured to aid the practitioner in connecting each coupler 260 to the correct corresponding coupling site on the recipient's body.
  • the support member 220 can have an axial elongated portion 221 aligned with a central axis 270 .
  • the support member 220 can further include two transverse elongated portions 222 (shown as a first transverse elongated portion 222 a and second transverse elongated portion 222 b) arranged transverse to the central axis 270 .
  • the coupler support 200 generally and the elongated portions 221 , 222 in particular can be configured to be spaced apart from corresponding coupling sites on the recipient's back, so as not to interfere with the operation of attaching the couplers 260 to the recipient.
  • the axial elongated portion 221 can have a length of about 11 inches ⁇ 0.25 inch (measured from the exit attachment point 224 ).
  • the transverse elongated portions 222 a , 222 b can have lengths of about 6.8 inches and about 7.5 inches, respectively, ⁇ 0.25 inch.
  • the elongated portions 221 , 222 can have other dimensions.
  • each coupler 260 can be positioned proximate to its corresponding coupling site to aid the practitioner in connecting the couplers with the appropriate coupling site, as described below with reference to FIG. 24 .
  • FIG. 24 is a partially schematic, top isometric view of the coupler support 200 (shown in phantom lines) placed in position on the back of a recipient.
  • the coupler support 200 is shown schematically in FIG. 24 without the couplers 260 .
  • the central axis 270 of the coupler support 200 is aligned with a body longitudinal axis 271 (such as the spine) to position the coupler support 200 proximate to a coupling area 280 on the recipient.
  • the coupling area can be on the recipient's back (as shown in FIG. 24 ) or, alternatively the coupling area can be on the recipient's neck, head, leg or other body part.
  • the coupler support 200 When the coupler support 200 is in position on the coupling area 280 , the elongated portions 221 , 222 a and 222 b can flex to conform to the shape of the recipient's body in the coupling area 280 . Accordingly, the coupler support 200 can be less likely to be dislodged from the recipient's body and can more accurately align the couplers 260 with the appropriate portions of the coupling area 280 .
  • the coupling area 280 includes a plurality of coupling positions or sites 281 (shown as 281 a - j ) at which a corresponding plurality of electrode assemblies 230 (shown as 230 a - j ) are attached.
  • the electrode assemblies 230 are arranged in cathode/anode pairs with five circuits formed by electrode assembly pairs 230 a and 230 b ; 230 c and 230 d ; 230 e and 230 f ; 230 g and 230 h ; and 230 i and 230 j .
  • each engagement member 240 (shown as 240 a - j ) is positioned proximate to its corresponding electrode assembly 230 a - j .
  • those engagement members 240 that are to be coupled with electrode assemblies 230 close to the body longitudinal axis 271 are positioned close to the central axis 270 of the coupler support 200 .
  • Those engagement members 240 that are to be coupled with electrode assemblies 230 further away from body longitudinal axis 271 are positioned further away from the central axis 270 of the coupler support 200 .
  • couplers 260 are positioned closer to the one corresponding electrode assembly 230 to which that coupler 260 is to be connected than to any other electrode assembly. As a result, practitioners will be less likely to link the couplers 260 to the incorrect electrode assembly 230 .
  • FIG. 25 is a top plan view of the coupler support 200 with the couplers 260 removed so that the tops of the engagement members 240 a - j are visible.
  • the engagement members 240 a - j can be marked to indicate which circuit the corresponding couplers 260 are connected to.
  • the engagement members 240 a and 240 b can be marked with a numeral “1” to indicate that the couplers 260 removed from these engagement members are connected to the recipient to form circuit number “1.”
  • An advantage of this arrangement is that if the control unit 62 ( FIG. 9 ) indicates that circuit number “1” is faulty or defective, the practitioner can easily narrow the field of potentially faulty couplers 260 to the two couplers 260 removed from engagement members 240 a and 240 b.
  • the coupler support 200 can include other features to further aid the practitioner in attaching the couplers 260 to the correct coupling site 281 .
  • the engagement member 240 a can be can be offset to the right side of the central axis 270 and the engagement member 240 b can be offset to the left side of the central axis 270 so that the practitioner will be more likely to connect the corresponding couplers 260 a , 260 b ( FIG. 24 ) to the appropriate coupling site 281 a , 281 b .
  • the engagement members 240 a , 240 e , 240 f , 240 i and 240 j positioned on the right side of the central axis 270 can have a different color than the engagement members 240 b , 240 c , 240 d , 240 g and 240 h positioned on the left side of the central axis 270 .
  • the overall shape of the coupler support 200 and in particular, an outline defined by the positions of the engagement members 240 , is generally similar to an outline defined by the positions of the coupling sites 281 .
  • the outline defined by the engagement members can also correspond to the outline defined by the coupling sites.
  • the relative longitudinal and lateral locations of the engagement members 240 can correspond at least roughly with the relative longitudinal and lateral locations of the coupling sites 281 on the recipient's body.
  • FIG. 26 is a top isometric view of a portion of a coupler support 300 having a transverse elongated portion 322 a with an engagement member 340 in accordance with another embodiment of the invention.
  • the overall shape of the coupler support 300 can be generally similar to that described above with reference to FIGS. 23-25 .
  • the engagement member 340 can include an aperture 341 positioned to receive the housing of a coupler, such as the coupler 260 described above with reference to FIG. 23 or the coupler 60 described above with reference to FIGS. 4-8 .
  • the engagement member 340 can include a pair of entrance slots 342 positioned to receive the pegs 70 ( FIG. 5 ) of the coupler 60 .
  • the coupler 60 can be rotated clockwise to move the pegs 70 into transverse locking slots 343 . Accordingly, an advantage of this arrangement is that it can securely, yet removably, engage the coupler 60 .
  • FIG. 27 is a top isometric view of a portion of a coupler support 400 having a transverse elongated portion 422 a with an engagement member 440 in accordance with another embodiment of the invention.
  • the engagement member 440 can include an aperture 441 configured to receive a clamping coupler 460 , such as an alligator clip.
  • the clamping coupler 460 can be attached directly to a percutaneous acupuncture needle 402 or another percutaneous or transcutaneous device. When the clamping coupler 460 is not attached to the needle 402 , it can be removably positioned in the aperture 441 while remaining connected to an electrical link 450 , such as a cable.
  • an electrical link 450 such as a cable.
  • the coupler support 400 can include an engagement member 440 a having a post shape.
  • the clamping coupler 460 can be clamped to the engagement member 440 a to support the coupler 460 relative to the coupler support 400 .
  • the clamping coupler 460 can be attached to a percutaneous electrode, such as the electrode 102 described above with reference to FIG. 22 .
  • the coupler 460 (or other couplers) can be attached to a transcutaneous electrical nerve stimulation system.
  • a clamping coupler 660 can be clamped to a diagnostic electrode, such as a patch electrode or an EMG needle electrode 630 of the type available from SLE of South Croydon, England.
  • a plurality of the couplers 660 (one of which is shown in FIG. 29 ) can be connected to a support 600 (shown schematically in FIG.
  • the support 600 can be connected with a bundled link 651 to a care unit 690 .
  • the care unit 690 can include a diagnostic instrument that receives electrical signals from the coupler 660 , rather than providing electrical signals to the coupler 660 . Accordingly, the support 600 can aid the practitioner in coupling the plurality of couplers 660 to the correct corresponding electrode 630 .
  • FIG. 30 is a partially schematic view of a coupler support 700 that can aid the practitioner in delivering medicament to a plurality of coupling sites on the recipient in accordance with another embodiment of the invention.
  • the coupler support 700 can include a plurality of medicament links 750 (one of which is shown in FIG. 30 ), such as a length of drug delivery tubing.
  • Each link 750 can include a coupler 760 for attaching to a needle or other drug delivery device 730 inserted into the recipient.
  • the individual medicament links 750 can be bundled together to form a bundled link 751 which is connected to a care unit 790 .
  • the care unit 790 can include a pump, drip bag, or other arrangement for providing liquid medicament to the coupler support 700 and the recipient.
  • a feature of embodiments of the coupler support arrangements described above with reference to FIGS. 11 and 23 - 30 is that the supports are configured to position the couplers proximate to the appropriate coupling location. Accordingly, practitioners, including relatively inexperienced practitioners, can be less likely to connect the couplers to an incorrect coupling location.
  • An advantage of this arrangement is that the couplers can provide more reliable and/or more efficacious therapy and/or diagnostic information.
  • a further advantage is that the practitioner can more quickly connect the couplers to the recipient, increasing the efficiency with which the practitioner can provide therapy and/or diagnostic information.
  • a single support can accommodate a wide variety of applications.
  • a single support can be used with recipients ranging in height from about 4.5 feet to about 6.5 feet, as discussed above.
  • a single coupler support can also be used with recipients having a wide variety of body shapes.
  • a single coupler support can be positioned on recipients having a variety of postures. For example, a single coupler support can rest on the recipient's back whether the recipient is prone, leaning over, or partially upright, while still allowing the couplers to be connected to the appropriate coupling locations.
  • the couplers can be connected directly to the recipient rather than being connected to an intermediate device such as an electrode (i.e., the electrode can be integrated with the coupler).
  • the coupler locations of the support member can include posts or columns, apertures, or any other feature that removably carries the couplers. Accordingly, the invention is not limited except as by the appended claims.

Abstract

A method and apparatus for supporting couplers for therapy administration and/or monitoring. The apparatus can include a support member configured to rest on a body of a recipient proximate to a coupling area. The support member can include a first coupler location configured to removably carry a first coupler proximate to a first coupling position of the body of the recipient. A second coupler location of the support member is configured to removably carry a second coupler proximate to a second coupling position of the body of the recipient. The first and second coupler locations can be arranged to guide the practitioner to connect the couplers properly to the body. For example, the first coupler location can be positioned closer than the second coupler location to the first coupling position. Accordingly, practitioners can be more likely to connect the first and second couplers to the correct coupling position on the body of the recipient.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation-in-part of: (1) U.S. application Ser. No. 09/452,477, titled “Percutaneous Electrical Therapy System with Electrode Entry Angle Control,” filed Dec. 1, 1999; and (2) U.S. application Ser. No. 09/666,931, titled “Method and Apparatus for Repositioning a Percutaneous Probe,” filed Sep. 21, 2000, both incorporated herein in their entireties by reference.
  • TECHNICAL FIELD
  • This invention relates generally to apparatuses and methods for coupling therapeutic and/or monitoring equipment to a patient.
  • BACKGROUND
  • Electrical therapy has long been used in medicine to treat pain and other conditions. For example, transcutaneous electrical nerve stimulation (TENS) systems deliver electrical energy through electrode patches placed on the surface of a patient's skin to treat pain in tissue beneath and around the location of the patches. However, the TENS systems may not adequately alleviate pain in certain circumstances.
  • More, recently, a technique in which electrodes are placed through the patient's skin into the target tissue has been proposed. Percutaneous Neuromodulation Therapy (“PNT”) (also sometimes called Percutaneous Electrical Nerve Stimulation or “PENS”) using percutaneously placed electrodes achieves significantly better pain relief results than TENS treatments using skin surface electrodes. This therapy is described in Ghoname et al., “Percutaneous Electrical Nerve Stimulation for Low Back Pain,” JAMA 281:818-23 (1999); Ghoname et al., “The Effect of Stimulus Frequency on the Analgesic Response to Percutaneous Electrical Nerve Stimulation in Patients with Chronic Low Back Pain,” Anesth. Analg. 88:841-6 (1999); Ahmed et al., “Percutaneous Electrical Nerve Stimulation (PENS): A Complementary Therapy for the Management of Pain Secondary to Bony Metastasis,” Clinical Journal of Pain 14:320-3 (1998); and Ahmed et al., “Percutaneous Electrical Nerve Stimulation: An Alternative to Antiviral Drugs for Herpes Zoster,” Anesth. Analg. 87:911-4 (1998). The contents of these references are incorporated herein by reference.
  • Thus far, PNT practitioners have used percutaneously placed acupuncture needles attached to waveform generators via cables and alligator clips to deliver the therapy to the patient. One feature of conventional PNT systems is that they typically include a number of electrical cables that must be properly connected to the corresponding percutaneous electrodes to deliver effective electrical therapy. Accordingly, a drawback with these conventional systems is that it can be difficult (particularly for inexperienced practitioners) to connect each electrical cable to the proper corresponding electrode. This drawback is shared as well by other systems that require multiple connections to the patient. Such systems include electrical monitoring systems and drug delivery systems.
  • SUMMARY
  • The invention is directed to apparatuses and methods for supporting therapeutic and/or diagnostic couplers for removable coupling to a recipient. An apparatus in accordance with one aspect of the invention can include a support member configured to rest on a body of the recipient proximate to a coupling region. The support member can include a first coupler location configured to removably carry a first coupler proximate to a first coupling position of the body of the recipient. The support member can further include a second coupler location configured to removably carry a second coupler proximate to a second coupling position of the body of the recipient. In one aspect of the invention, the support member can be spaced apart from the first and second coupling positions. In another aspect of the invention, the support member can be elongated along a support member axis and the first coupler location can be positioned closer than the second coupler location to the support member axis. In still another aspect of the invention, the first coupler location can be positioned closer than the second coupler location to the first coupling position. Accordingly, the apparatus can guide a practitioner to connect the couplers to the correct coupling position.
  • In another aspect of the invention, the support member can be flexible and resilient to conform to a surface of the body, and can be shaped to rest on at least one of a back, a neck, a head, and a leg of the recipient. The apparatus can further include a flexible link coupled between the first coupler and the support member. The link can remain connected between the first coupler and the support member when the first coupler is moved from an attached position to a detached position and then to a coupled position with the coupler coupled to the body of the recipient. The link can include an electrical cable configured to be coupled to a source of electrical pulses, an electrical cable configured to be coupled to a signal monitor, and/or a length of tubing configured to be coupled to a source of liquid medicament.
  • In yet another aspect of the invention, the first and second coupling positions can be two of a larger plurality of coupling positions and the first and second coupler locations can be two of a larger plurality of coupler locations. An outline of the coupling positions can define a first shape and an outline of the coupler locations can define a corresponding second shape at least generally similar to the first shape.
  • The invention is also directed toward a method for coupling therapy and/or monitoring equipment to a recipient. The method can include positioning a support member against a body of a recipient proximate to a coupling area, supporting a first coupler relative to the body at a first coupler location of the support member proximate to a first coupling position of the body, and supporting a second coupler relative to the body at a second coupler location of the support member proximate to a second coupling position of the body. In one aspect of the invention, the support member can be elongated along a support member axis and the first coupler location can be positioned closer than the second coupler location to the first coupling position and/or to the support member axis. In another aspect of the invention, the support member can be spaced apart from the first and second coupling positions. The method can further include removing the first coupler from the support member and coupling the first coupler to the body at the first coupling position, and removing the second coupler from the support member and coupling the second coupler to the body at the second coupling position.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A-G are schematic renderings of a percutaneous electrical therapy system according to one embodiment of this invention.
  • FIG. 1A shows electrode and angle of insertion assemblies wherein the electrode is in an undeployed and uninserted state.
  • FIG. 1B shows the electrode and angle of insertion assemblies of FIG. 1A during deployment but prior to insertion of the electrode into a patient's tissue.
  • FIG. 1C shows the electrode and angle of insertion assemblies of FIG. 1A during deployment and insertion of the electrode into the patient's tissue.
  • FIG. 1D shows the electrode of FIG. 1A inserted into the patient's tissue.
  • FIG. 1E shows the electrode of FIG. 1A attached to a control unit to provide percutaneous electrical therapy.
  • FIG. 1F shows the electrode and angle of insertion assemblies of FIG. 1A during undeployment but prior to removing the electrode from the patient's tissue.
  • FIG. 1G shows the electrode and sharp point protection assemblies of FIG. 1A during undeployment and after removing the electrode from the patient's tissue.
  • FIGS. 2A-E are schematic renderings of a percutaneous electrical therapy system according to another embodiment of this invention.
  • FIG. 2A shows a percutaneous electrical therapy system with electrode and angle of insertion assemblies wherein the electrode is in an undeployed and uninserted state.
  • FIG. 2B shows the percutaneous electrical therapy system of FIG. 2A during deployment, but prior to insertion, of the electrode.
  • FIG. 2C shows the percutaneous electrical therapy system of FIG. 2A with the electrode in a deployed and inserted state.
  • FIG. 2D shows the percutaneous electrical therapy system of FIG. 2A during undeployment of the electrode.
  • FIG. 2E shows the percutaneous electrical therapy system of FIG. 2A after the electrode has been undeployed.
  • FIG. 3 shows an electrode montage for use in percutaneous neuromodulation therapy to treat low back pain. FIG. 4 is an exploded sectional view of an electrode and angle of insertion assembly according to yet another embodiment of this invention.
  • FIG. 5 is a partially exploded elevational view of the embodiment of FIG. 4.
  • FIG. 6 is an elevational view of the embodiment of FIG. 4 showing the electrode and angle of insertion assemblies and a coupler.
  • FIG. 7 is a sectional view of the embodiment of FIG. 4 showing the electrode and angle of insertion assemblies and a coupler.
  • FIG. 8 is a sectional view of the embodiment of FIG. 4 showing the coupler in engagement with the electrode and angle of insertion assemblies prior to insertion of the electrode into a patient's tissue.
  • FIG. 9 is a sectional view of the embodiment of FIG. 4 with the electrode in its deployed and inserted state.
  • FIG. 10 shows a montage for using the embodiment of FIG. 4 to treat low back pain with the electrodes in a partially deployed but uninserted state.
  • FIG. 11 shows the electrode montage of FIG. 10 at the beginning of the electrode insertion step.
  • FIG. 12 shows the electrode montage of FIG. 10 with the electrodes deployed, inserted and attached to a control unit to provide electrical therapy to the patient.
  • FIG. 13 is an exploded view of an electrode introducer and angle of insertion assembly of yet another embodiment of this invention.
  • FIG. 14 is a partial sectional view of the introducer and angle of insertion assembly of FIG. 13.
  • FIG. 15 is a sectional view of the introducer and angle of insertion assembly of FIG. 13.
  • FIG. 16 is an elevational view of gear assemblies of the introducer and angle of insertion assembly of FIG. 13.
  • FIG. 17 shows part of the electrode assembly of the embodiment of FIGS. 13-16 in a montage used for treating low back pain using PNT.
  • FIG. 18 is an elevational view showing the introducer of FIG. 13 in the process of deploying an electrode.
  • FIG. 19 is a sectional view showing the introducer of FIG. 13 in the process of deploying an electrode, prior to insertion of the electrode.
  • FIG. 20 is a sectional view showing the introducer of FIG. 13 in the process of deploying an electrode, during insertion of the electrode.
  • FIG. 21 is a sectional view showing the introducer of FIG. 13 in the process of deploying an electrode, also during insertion of the electrode.
  • FIG. 22 is a sectional view of an inserted electrode assembly of the embodiment of FIGS. 13-16.
  • FIG. 23 is a partially schematic, top isometric view of a coupler support in accordance with an embodiment of the invention.
  • FIG. 24 is a partially schematic, top isometric view of a coupler support positioned on the back of a recipient in accordance with another embodiment of the invention.
  • FIG. 25 is a partially schematic, top plan view of a support member positioned near coupling positions in accordance with another embodiment of the invention.
  • FIG. 26 is a top isometric view of a portion of a coupler support configured to support a coupler in accordance with another embodiment of the invention.
  • FIG. 27 is a top isometric view of a portion of a coupler support having an aperture configured to receive a clamp-type coupler in accordance with still another embodiment of the invention.
  • FIG. 28 is a top isometric view of a portion of a coupler support having a post configured to be clamped by a clamp-type coupler in accordance with yet another embodiment of the invention.
  • FIG. 29 is a partially schematic illustration of an arrangement that includes a coupler support configured to support couplers for receiving diagnostic information in accordance with yet another embodiment of the invention.
  • FIG. 30 is a partially schematic illustration of an arrangement that includes a coupler support configured to support a plurality of couplers that administer liquid medicament in accordance with still another embodiment of the invention.
  • DETAILED DESCRIPTION
  • Percutaneous electrical therapy systems, such as PNT systems, deliver electric current to a region of a patient's tissue through electrodes that pierce the skin covering the tissue. The electric current is generated by a control unit external to the patient and typically has particular waveform characteristics such as frequency, amplitude and pulse width. Depending on the treatment or therapy being delivered, there may be one electrode containing both a cathode and an anode or a plurality of electrodes with at least one serving as a cathode and at least one serving as an anode.
  • The electrode has a sharp point not only to facilitate insertion through the patient's skin but also to enhance local current density during treatment. The placement and location of the electrode point is therefore an important aspect of the therapy. The electrodes must also be properly coupled to the control unit to form a complete circuit for delivering therapeutic electric current to the patient.
  • FIGS. 1A-G are block diagrams showing deployment and use of a percutaneous electrical therapy system and electrode assembly in accordance with an embodiment of the invention. As shown in FIGS. 1A and 1B, the system can include an electrode 1 having a sharp point 2 at its distal end and a housing 4 surrounding at least the sharp point 2 when the electrode is in its undeployed and uninserted states. The undeployed and uninserted states include pre-deployment and post-deployment states of the electrode 1. The housing 4 can have an aperture 5 at its distal end. An actuator 6 can interact with a handle 11 at the proximal end of electrode 2 as shown to move the electrode 1.
  • Deployment of the electrode assembly can include the steps taken to place the electrode assembly in proper position and condition for use in electrical therapy. FIG. 1A shows the electrode assembly in an undeployed (pre-deployed) state. During deployment, the distal face 7 of housing 4 is placed against a patient's skin 22, as shown in FIG. 1B. This action supports housing 4 with respect to the patient's skin, thereby controlling the angle between the housing and the patient's skin. Electrode 2 is then inserted through aperture 5 into the tissue underlying the patient's skin by moving actuator 6 distally, as shown in FIG. 1C. As it moves, actuator 6 (and therefore electrode 2) is supported by housing 4 to control the angle at which the electrode 1 enters into the patient's tissue.
  • The actuator 6 may have a limit stop 9 element cooperating with a limit stop area 8 of the housing 4 to limit distal motion of the actuator 6 and to control the depth of insertion of the sharp point 2 of the electrode 1. In one embodiment, for example, when the electrical therapy system is used to provide percutaneous neuromodulation therapy, the predetermined electrode depth is 3 cm. Other electrode depths may be used, of course, depending on the intended application and therapy.
  • After insertion, the housing 4 and the actuator 6 (which have heretofore acted as an electrode introducer) can be removed, as shown in FIG. 1D. The electrode 1 can be connected to a control unit 10 via a conductor or cable 16. For use with PNT, the control unit 10 can supply a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, a frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 μsec and 1 msec. Other electrical waveforms having other parameters may be used, of course, depending on the therapy to be provided. Also, while FIG. 1E shows only one electrode connected to the control unit, it should be understood that a plurality of electrodes may be connected to a single control unit.
  • After completion of the electrical therapy, the electrode assembly can be undeployed. In an embodiment shown in FIG. 1F, the aperture 5 of housing 4 is placed over the handle portion 11 of electrode 1. Housing 4 may be the same housing used to deploy and insert the electrode (i.e., the electrode introducer), or it may be an entirely different assembly (e.g., an electrode remover). The sharp point 2 of electrode 1 is then drawn into housing 4 of sharp point protection assembly 3 by moving actuator 6 proximally, as shown in FIG. 1G.
  • FIGS. 2A-E are block diagrams showing another embodiment of the invention. In one aspect of this embodiment, a control unit 10 is connected to an electrode 12 within an electrode assembly 13 via a conductor 16. As above, for use with PNT, the control unit 10 can supply a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, a frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 μsec and 1 msec. In other embodiments, the control unit 10 can supply electrical current having other characteristics. As shown in its undeployed state in FIG. 2A and in its uninserted stated in FIG. 2B, the system can include a housing 18 surrounding the sharp point 20 of electrode 12 when the electrode point 20 has not yet been inserted through the patient's skin 22.
  • To begin deployment, a distal face 21 of the housing 18 is placed against the patient's skin 22, as shown in FIG. 2B. As with the previous embodiment, this action supports the housing 18 with respect to the patient's skin, thereby controlling the angle between the housing and the patient's skin. The sharp point 20 of electrode 12 is then inserted through an aperture 24 into the tissue underlying the patient's skin by moving an actuator 19 distally, as shown in FIG. 2C. As it moves, the actuator 19 (and therefore the electrode 12) is supported by the housing 18 to control the angle at which the electrode enters into the patient's tissue.
  • The actuator 19 may be part of the electrode assembly 13 or a separate component of the system. The actuator 19 may also have a limit stop element 23 that cooperates with a limit stop area 17 of housing 18 to limit distal movement of actuator 19, thereby controlling the depth of insertion of electrode 12. In one embodiment, for example, when the electrical stimulation system is used to provide percutaneous neuromodulation therapy, the predetermined electrode depth is approximately 3 cm, although other electrode depths may be used depending on the application. The control unit 10 may then provide the appropriate therapy to the patient through the electrode 12 and any other electrodes connected to it.
  • During undeployment, the actuator 19 can draw the electrode 12 back proximally into the housing 18. After the electrode 12 is removed from the patient's skin, the housing 18 of sharp point protection assembly 14 once again surrounds the sharp point 20 of the now uninserted electrode 12, as shown in FIGS. 2D and 2E. The actuator 19 helps enable this operation to occur without ever exposing the sharp point 20 of the electrode 12 when the sharp point 20 is no longer in the patient. In fact, the operator of the electrode assembly never sees the sharp point 20 of the electrode 12. Thus, sharp point protection assembly 14 shields the potentially contaminated portion of the undeployed electrode 12 and protects the patient's caregiver or other bystander from unintended contact with the sharp point 20 of the electrode 12 before, during and after electrical therapy.
  • While FIGS. 2A-E show the electrode connected to the control unit prior to deployment and insertion of the electrode into the patient's skin, the connection between the control unit and the electrode could be made during deployment or after insertion. Also, while FIGS. 2A-E show only one electrode connected to the control unit, it should be understood that a plurality of electrodes may be connected to a single control unit, as called for by the desired electrical stimulation treatment.
  • To use the percutaneous electrical therapy systems of FIGS. 1A-G and FIGS. 2A-E to treat a patient, one or more electrodes are inserted through the patient's skin into the underlying tissue. As an example, to treat low back pain using PNT with unipolar electrodes, an array or montage such as that shown in FIG. 3 may be used. The “T12”-“S1” designations refer to the patient's vertebrae. The control unit or generator supplies current pulses between pairs of electrodes for durations of a few minutes to several hours, preferably delivering the current-regulated waveform described above. Thirty-minute treatments are recommended in the Ghoname et al. low back pain treatment articles.
  • FIGS. 4-12 show a system in accordance with another embodiment of this invention. An electrode assembly 30 can include a base 32, an electrode 34, and a plunger or actuator 36. The base 32 can have a flange or flared end 44 that is adapted to make contact with a patient's skin. The base 32 may be formed from any suitable polymer or metal, such as a high-density polyethylene (HDPE). The base 32 can be opaque so that the electrode 34 cannot be seen by a needle-shy patient.
  • The actuator 36 fits within a housing portion 40 of base 32 in a slidable arrangement. A locking assembly can prevent relative movement between the actuator 36 and the housing 40 of the base 32. In one embodiment, the locking assembly of the actuator 36 has integrally-formed resilient detents 48 on its exterior cylindrical surface. In the undeployed state of electrode assembly 30, the detents 48 mate with corresponding openings 50 in the base 32 to hold the actuator 36 and the base 32 in place with respect to each other to prevent the electrode 34 from moving outside of the protective housing 40 of the base 32, thereby providing sharp point protection. In other embodiments, mechanisms other than the detent and opening arrangement may be used to hold the actuator and base in place.
  • In one embodiment, the electrode 34 can include a 3-cm long 32-gauge stainless steel needle. Other sizes and materials may be used for the electrode 34, of course, without departing from the scope of the invention. The actuator 36 can be formed from HDPE as well, although other suitable materials may be used.
  • The electrode 34 can have a larger-diameter handle 52 at its proximal end. The handle 52 can fit within a channel 54 formed within the actuator 36. The channel 54 can have a narrow opening 56 at its distal end, with a diameter slightly larger than the diameter of electrode 34 but narrower than the diameter of handle 52 to hold electrode 34 in place within the actuator 36 after initial manufacture and assembly. In the undeployed state shown in FIG. 7, the sharp point 38 of electrode 34 is disposed within housing portion 40 of base 32, specifically, within a narrow channel 42 of the housing 40.
  • To deploy one or more electrode assemblies on a patient in order to provide electrical stimulation therapy (such as PNT), the distal surface 46 of the flange portion 44 of the base 32 can be mounted on the desired site on the patient's skin, preferably with a compressible adhesive pad (not shown) surrounding a ring 43 extending downward from surface 46 around an aperture 41 formed at the distal end of channel 42, although other means of attaching base 32 to the patient may be used as appropriate. This action aligns the base 32 with respect to the patient's skin. The flange portion 44 of the base 32 provides extra stability for the electrode assembly during electrode insertion and use.
  • A coupler or actuator tool 60 can be used to both insert the electrode and connect the electrode electrically with a control unit 62. The coupler 60 and the electrode assembly 30 can also interact to provide the sharp point protection assembly of this embodiment. When the distal end of the coupler 60 is placed against the proximal ends of the base 32 and the actuator 36, the exposed proximal end 64 of the electrode handle 52 makes electrical contact with a contact surface 66 within the coupler 60. The contact surface 66, in turn, can be electrically connected to the control unit 62 via a cable or other conductor 68.
  • The coupler 60 can have two oppositely disposed pegs 70 extending outwardly from the distal portion of its cylindrically surface. The pegs 70 can mate with two corresponding slots 72 in the actuator 36 and with two corresponding grooves 74 in the base 32. The second of the two slots 72 and the second of the two grooves 74 are each opposite the slot 72 and groove 74, respectively, shown in FIGS. 4 and 5. When connecting the coupler 60 to the electrode assembly 30, the pegs 70 move along longitudinal portions 76 of the slots 72 and along longitudinal portions 78 of the grooves 74. Concurrently, the exposed distal end 64 of the electrode handle 52 begins to make sliding contact with the contact surface 66 of actuator tool 60 to create the electrical connection between coupler 60 and the electrode 32.
  • The coupler 60 can be rotated clockwise (looking down on the assembly), after the pegs 70 reach the end of the longitudinal portions 76 and 78. Accordingly, the pegs 70 move into short circumferential portions 80 and 82, respectively, of the slots 72 and the grooves 74. The length of the circumferential portions 80 of the slots 72 is less than the length of the circumferential portions 82 of the grooves 74. Continued movement of the pegs 70 along the circumferential portions 82 will therefore move the pegs 70 against the ends 81 of the circumferential slots 80. Further clockwise rotation of the coupler 60 will cause the actuator 36 to rotate clockwise as well, thereby moving the detents 48 out of the openings 50 and allowing the electrode 34 and the actuator 36 to move with respect to base 32.
  • Second longitudinal portions 84 of the grooves 74 can be formed in base 32 at the end of circumferential portions 82. Movement of the pegs 70 distally along the second longitudinal portions 84 pushes the pegs 70 against the distal edges of the circumferential slot portions 80, thereby moving the actuator 36 and the electrode 34 in a controlled fashion distally toward the patient's skin 22.
  • As it moves, the electrode 34 passes through the channel 42, and the sharp point of electrode 34 moves out through aperture 41. The channel 42 and the actuator 36 provide axial support to the electrode 34 during this forward movement and also, along with the support provided by the flange 44, provide entry angle guidance to the electrode 34. In addition, downward pressure on the patient's skin during electrode deployment can compress the compressible adhesive pad and press the ring 43 against the patient's skin 22, which helps ease electrode entry through the skin and also lessens the insertion pain experienced by the patient.
  • The alignment of the base 32 with respect to the patient's skin and the controlled movement of the actuator 36 and the electrode 34 within the base 32 can control the angle at which the electrode enters the tissue underlying the patient's skin. Distal movement of the electrode 34 and its actuator within the base 32 can continue until a distal surface 86 of a cylindrical cap portion 92 of the coupler 60 meets an annular surface 88 of housing 40. At this point, the sharp point 38 of the electrode 34 has extended a predetermined depth into the tissue underlying the patient's skin. In one embodiment, this predetermined depth is approximately 3 cm, and the depth can have other values depending on the treatment to be performed.
  • The electrode assembly 30 can also include a deployed electrode holding mechanism. In one aspect of this embodiment, an interference fit between the inner surface of channel 42 and the outer surface 55 of channel 52 performs this function.
  • Electrical stimulation treatment may begin once the electrodes have been deployed and inserted. The control unit 62 can supply stimulation current to the electrodes, e.g., in the manner described in the Ghoname et al. articles. The electrical waveform provided by the control unit depends on the application. For example, in one embodiment, the control unit 62 can provide a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 μsec and 1 msec. In other embodiments, the control unit 62 can provide electrical current at other frequencies.
  • The interaction of the coupler 60 and the base 32 can provide stability to the electrode 34 and its electrical connection to the control unit during treatment by holding the electrode in place, by providing strain relief for tugging forces on the cable 68, and by providing a robust mechanical connection. It should also be noted that in one aspect of these embodiments, the sharp point of the electrode 34 is not exposed to the operator or to any other bystander at any point during deployment and use of the electrode assembly.
  • After treatment has been completed, the electrode may be removed from the patient. To do so, the coupler 60 can be moved proximally away from the patient. As the pegs 70 move proximally along the longitudinal portions 84 of the grooves 74, the pegs 70 push against the proximal edges of the actuator's circumferential slot portions 80, thereby moving the actuator 36 and the electrode 34 proximally as well. When the pegs 70 reach the proximal end of the longitudinal groove portions 84, the sharp end 38 of the electrode 34 is out of the patient and safely inside the housing 40 of the base 32. Counterclockwise movement of the coupler 60 moves the pegs 70 along the circumferential portions 80 and 82 of the slot 72 and the groove 74, respectively. Because the circumferential portion 80 is shorter than the circumferential portion 82, this counterclockwise movement will turn the actuator 36 counterclockwise.
  • At the limit of the counterclockwise movement, the detents 48 move back into the openings 50 to prevent further movement of the electrode and the actuator with respect to the base 32. Further distal movement of the coupler 60 moves the pegs 70 distally along the longitudinal portions 76 and 78 of the slot 72 and the groove 74, respectively, to disconnect the coupler 60 from the electrode assembly 30. The base 32 can then be removed from the patient.
  • FIGS. 10-12 show the use of the electrode and sharp point protection assemblies of FIGS. 4-9 to treat low back pain using PNT. As shown in FIG. 10, ten electrode assemblies 30 a-j are arranged in a montage on the patient's back and attached with adhesive. Next, ten couplers 60 a-j are attached to the ten electrode assemblies 30 a-j. In one embodiment (shown in FIG. 11), the couplers 60 a-j are supported or carried prior to deployment by a coupler support 61 (FIG. 12). In one aspect of this embodiment, the coupler support 61 can include a generally flat, rigid support member 63 having ten engagement members 65 positioned at corresponding coupler locations of the support member 63. Each engagement member 65 can be configured to removably support or carry one of the couplers 60. For example, each engagement member 65 can include a post projecting upwardly from the support member 63 to be removably received in a corresponding axial aperture of the coupler 60. As shown in FIG. 12, each coupler 60 can be connected to the support member 63 with an individual cable 68 a-j. The individual cables 68 a-j can be bundled together to form a link 69 (such as a multi-wire cable) that provides electrical communication between the couplers 60 and a control unit 62.
  • In another aspect of this embodiment, an arrangement of the engagement members 65 on the support member 63 can correspond to an arrangement of the electrode assemblies 30 a-j on the patient's back. For example, when the electrode assemblies 30 a-j are connected to the patient at ten sites arranged in two rows on each side of the patient's spine, the engagement members 65 can be arranged in two rows, one on each side of a central axis 67 (FIG. 11) that can be aligned with the patient's spine. Accordingly, the arrangement of the engagement members 65 can guide the practitioner to connect each coupler 60 to the proper electrode assembly 30. Because each electrode assembly 30 is paired with another to define a complete electrical circuit (with one electrode serving as an anode and an adjacent electrode serving as a cathode), it can be important to correctly match the individual cable 68 with the corresponding electrode assembly. For example, if a given electrode assembly 30 serving as an anode is inadvertently placed too distant from the corresponding electrode assembly 30 serving as a cathode, the current applied to the electrode assemblies may be too weak to be effective. Furthermore, when the characteristics of the electrical signals supplied to each circuit are controlled separately, it may not be clear which circuit is being controlled if the couplers 60 are attached to the wrong electrode assemblies. Accordingly, the coupler support 61 can increase the effectiveness of the electrical stimulation therapy by reducing the likelihood that the couplers 60 will be incorrectly deployed. In other embodiments, the coupler support 61 can have other configurations and can support couplers having other configurations, as described below with reference to FIGS. 23-30.
  • Once each electrode assembly 30 has been actuated by its respective coupler 60 to insert an electrode into the patient's tissue (as shown in FIG. 12), the control unit 62 provides electrical signals to treat the patient. As described above, half the electrodes (e.g., assemblies 30 b, 30 d, 30 g, 30 h and 30 i) can serve as anodes, and the other half as cathodes. In one embodiment, the control unit 62 can provide a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 μsec and 1 msec. to treat the patient's low back pain using PNT.
  • FIGS. 13-22 illustrate an apparatus in accordance with another embodiment of the invention. In one aspect of this embodiment, an electrode introducer and an alignment member mounted on the patient's skin provide an electrode angle of insertion assembly controlling the electrode's angle of entry into the patient's tissue. In a further aspect of this embodiment, an electrode introducer 100 shown in FIGS. 13-16 and 19-21 can insert multiple electrodes. It should be understood that the principles of this invention could be applied to an introducer designed to hold and insert any number of electrodes.
  • Twelve electrodes 102 are disposed within a magazine 103 rotatably mounted within a housing 104. In one embodiment, the housing 104 is a two-part injection molded polystyrene assembly. As shown in FIG. 14, the magazine 103 rotates about a hub 105 mounted on supports formed in housing 104. A leaf spring 106 mates with one of twelve radial grooves 108 formed in the magazine 103 to form a twelve-position ratchet mechanism for the rotatable magazine 103 in the housing 104.
  • The magazine 103 can have twelve electrode chambers 115 arranged radially about the hub 105. When the introducer 100 is completely full, each chamber 115 contains one electrode 102. The diameter of an upper portion 118 of the chamber 115 is sized to form an interference fit with the wider portions 112 and 114 of electrode handle portion 107 of electrode 102. A lower wide portion 114 of electrode 102 can be formed from a compressible material. The diameter of a lower portion 119 of the chamber 115 is slightly larger so that there is no interference fit between the lower portion 119 and the electrode handle 107, for reasons explained below. Each time the leaf spring 106 is within a groove 108, the opening 106 of a magazine chamber 115 is lined up with the aperture 117 of the introducer 100, as shown in FIGS. 14 and 15.
  • A slide member 109 is disposed on a rail 110 formed in the housing 104. Extending longitudinally downwardly from the slide member 109 is a drive rod 111, and extending longitudinally upwardly from the slide member 109 is a gear rack 120. The teeth of the gear rack 120 cooperate with the teeth on a rotational gear 122 mounted about a shaft 124 extending into a shaft mount 126 formed in the housing 104. A second set of teeth are mounted on a smaller diameter rotational gear 128 (shown more clearly in FIG. 16) which is also mounted about the shaft 124. The gears 122 and 128 rotate together about the shaft 124.
  • The teeth of the smaller diameter gear 128 mesh with the teeth of a second gear rack 130 extending from a longitudinally-movable actuator 132. A spring 134 mounted between the actuator 132 and a spring platform 136 biases the actuator 132 away from the housing 104.
  • To deploy the electrode assembly of this embodiment, a flexible and compressible annular patch 140 is placed on the patient's skin at the desired site, preferably with an adhesive (not shown). For example, to treat low back pain using PNT, the arrangement or montage shown in FIG. 17 may be used. In this montage, five electrodes serve as cathodes and five serve as anodes.
  • As shown in FIGS. 19 and 20, the patch 140 has an annular rigid member 141 disposed in its center and extending upwardly from it. The rigid member 141 has a smaller diameter opening 142 leading to a larger diameter opening 144. The diameter of the opening 142 is slightly smaller than the lower wide portion 114 of the handle portion 107 of the electrode 102 and slightly larger than the diameter of the central portion 113 of handle portion 107 of the electrode 102.
  • After the patch 140 is in place, the distal end of the introducer 100 is placed against the patch 140 so that the introducer aperture 117 surrounds the upwardly extending portion of rigid patch member 141, as shown in FIG. 18. This interaction aligns the opening 116 of one of the introducer's magazine chambers 115 with the opening 142 of the rigid member 141 and helps control the electrode's angle of entry, as shown in FIG. 19. Downward pressure on the introducer 100 compresses the patch 140, thereby causing the upper surface of the rigid member 141 to engage a lower surface of the magazine 103, and pressing the rigid member 141 downward into the patient's skin 22. This pressure on the patient's skin around the insertion site can reduce the pain caused by inserting the electrode.
  • Depressing the actuator 132 moves the gear rack 130 distally, which causes the gears 128 and 122 to rotate. Because the diameter and tooth count of the gear 128 differ from the diameter and tooth count the gear 122, the gear rack 120 moves longitudinally a much greater distance than the corresponding longitudinal movement of the gear rack 130. This feature enables the electrode to be inserted its required distance into the patient's skin using only a comparatively small movement of the operator's thumb. Distal movement of the gear rack 120 is guided by the movement of the slide member 109 along the rail 110.
  • As the slide member 109 moves distally, the drive rod 111 moves into a magazine chamber 115 until the distal end of the drive rod 111 engages the top surface of the electrode's handle portion 107. As shown in FIG. 20, further distal movement of the drive rod 111 pushes the electrode 102 downwardly so that the sharp point 108 of the electrode 102 leaves the introducer housing and enters the patient's skin 22 and the tissue beneath the skin. The chamber 115 provides axial stability to the electrode 102 during insertion.
  • When the top portion 112 of the electrode handle portion 107 leaves the smaller diameter portion 118 of the magazine chamber 115, it enters the larger diameter portion 119 of the chamber 115. At this point (shown in FIG. 21), because the diameter of chamber portion 119 is wider than the diameter of the electrode handle 107, the electrode is no longer attached to the introducer 100.
  • Continued downward movement of the actuator 132 and the drive rod 111 pushes the lower larger diameter portion 114 of the electrode handle 107 through the smaller diameter portion 142 of rigid member 141 by compressing the handle portion 114. Further downward movement pushes the handle portion 114 into the larger diameter portion 144 of the rigid member 141 so that the rigid member's smaller diameter portion lies between the larger diameter portions 112 and 114 of the electrode handle 107. This interaction holds the electrode in place in the patient's tissue and helps provide depth control for electrode insertion. In this embodiment, the preferred depth of the electrode's sharp point 108 is approximately 3 cm, although the electrode may be inserted to other depths depending on the treatment to be performed. The slider member 109 also acts as a limit stop at this point when it engages the limit stop area 145 of housing 104, thereby also controlling electrode insertion depth.
  • The magazine 103 can be rotated to a new insertion position and placed against an empty patch 140 after insertion of each electrode until all electrodes have been deployed and inserted. A suitable electrical connector 148, such as an alligator clip, can be electrically connected to electrode 102 through an aperture (not shown) formed in the upper larger diameter portion 112 of electrode handle 107 to provide electrical communication between a control unit 150 and electrode 102 via a cable or other conductor 149, as shown in FIG. 22. The patch 140 can provide strain relief for the electrode 102 by preventing tugging forces on the cable 149 from dislodging the electrode from the patient, thereby helping keep the electrode in place. In one aspect of this embodiment, the sharp point of the electrode is not exposed to the operator or bystander at any point during the electrode deployment, insertion and electrical therapy treatment processes.
  • The control unit 150 supplies stimulation current to the electrodes, e.g., in the manner described in the Ghoname et al. articles. Once again, the electrical waveform provided by the control unit depends on the application. For example, in an embodiment of a system providing percutaneous neuromodulation therapy, the control unit 150 can provide a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 μsec and 1 msec.
  • In an alternative embodiment, the lower wide portion of the electrode handle can be formed from a rigid material and can have rounded camming edges. The central annulus of patch 140 in this alternative embodiment is either compressible or has a resilient camming opening under the camming action of the electrode handle.
  • FIG. 23 is a top isometric view of a coupler support 200 that supports or carries couplers 260 in accordance with another embodiment of the invention. In one aspect of this embodiment, the coupler support 200 includes a support member 220 and ten engagement members 240 positioned at coupler locations of the support member 220. Each engagement member 240 can removably support one of the couplers 260. In one aspect of this embodiment, the couplers 260 can be generally similar to the coupler 60 described above with reference to FIGS. 4-12. Alternatively, the coupler 260 can have other configurations, such as the configuration disclosed in co-pending U.S. application Ser. No. 09/666,931, entitled “Method and Apparatus for Repositioning a Percutaneous Probe,” incorporated above by reference. In other embodiments, the coupler can have other configurations, for example, those described below with reference to FIGS. 27-30.
  • When the couplers 260 are generally similar to the couplers 60 described above with reference to FIGS. 4-12, each engagement member 240 can have columnar or post shape and can be removably received in a downward facing aperture of the coupler 260. The engagement member 240 can extend a sufficient distance upwardly into the aperture of the coupler 260 to firmly support the coupler 260 relative to the support member 220. In other embodiments, the engagement member 240 can have other configurations (for example, when the coupler has other configurations), as described below with reference to FIGS. 26-30.
  • The coupler support 200 can include links 250 between the support member 220 and each coupler 260. In one aspect of this embodiment, the links 250 can include electrical cables to transmit electrical signals to the couplers 260 and to the patient or recipient to whom the couplers 260 are attached. In other embodiments, the links 250 can have other configurations, as described below with reference to FIGS. 27-30. In any of these embodiments, different links 250 can have different lengths to allow the corresponding coupler 260 to be coupled to the appropriate site on the recipient. Alternatively, each link 250 can have the same length, so long as the length is sufficient for each coupler 260 to be coupled to the proper site on the recipient. For example, in one embodiment, a single support member 220 with a single set of links 250 can be compatible with recipients ranging in height from about 4.5 feet to about 6.5 feet.
  • When the links 250 include electrical cables, each link 250 can enter the support member 220 at an entry attachment point 223. The links 250 can then pass through a cable channel 212 of the support member 220 and exit the support member 220 at an exit attachment point 224. The links 250 can be bundled together to form a bundled link 251 that can be attached to an electrical connector 252 for coupling to a source of electrical potential.
  • In one embodiment, the support member 220 can include an upper portion 210 bonded to a lower portion 211. The upper portion 210 can include the cable channel 212 and the engagement members 240. The support member 220 can be formed by molding the upper portion 210, inverting the upper portion 210, and laying a cable harness (which includes the bundled link 251 and the individual links 250) into the cable channel 212. The lower portion 211 can be attached to the upper portion 210 (for example, in an overmold process) to fix the harness into the support member 220. In other embodiments, the coupler support 200 can be formed with other techniques. In any of these embodiments, the support member 220 can include a flexible, soft durometer, bio-compatible, thermoplastic elastomeric material, such as Sanoprene®, available from Advanced Elastomeric Systems of Akron, Ohio. Accordingly, the support member 220 can conform to the shape of the recipient's body, as described below with reference to FIG. 24.
  • In a further aspect of this embodiment, the shape of the support member 220 and the positions of the engaging members on the support member 220 can be configured to aid the practitioner in connecting each coupler 260 to the correct corresponding coupling site on the recipient's body. For example, when the coupler support 200 is configured to administer electrical therapy to the recipient's back, the support member 220 can have an axial elongated portion 221 aligned with a central axis 270. The support member 220 can further include two transverse elongated portions 222 (shown as a first transverse elongated portion 222a and second transverse elongated portion 222b) arranged transverse to the central axis 270. In one aspect of this embodiment, the coupler support 200 generally and the elongated portions 221, 222 in particular can be configured to be spaced apart from corresponding coupling sites on the recipient's back, so as not to interfere with the operation of attaching the couplers 260 to the recipient. For example, in one embodiment, the axial elongated portion 221 can have a length of about 11 inches ±0.25 inch (measured from the exit attachment point 224). The transverse elongated portions 222 a, 222 b can have lengths of about 6.8 inches and about 7.5 inches, respectively, ±0.25 inch. In other embodiments, the elongated portions 221, 222 can have other dimensions. In any of these embodiments, each coupler 260 can be positioned proximate to its corresponding coupling site to aid the practitioner in connecting the couplers with the appropriate coupling site, as described below with reference to FIG. 24.
  • FIG. 24 is a partially schematic, top isometric view of the coupler support 200 (shown in phantom lines) placed in position on the back of a recipient. For purposes of clarity, the coupler support 200 is shown schematically in FIG. 24 without the couplers 260. In one aspect of this embodiment, the central axis 270 of the coupler support 200 is aligned with a body longitudinal axis 271 (such as the spine) to position the coupler support 200 proximate to a coupling area 280 on the recipient. The coupling area can be on the recipient's back (as shown in FIG. 24) or, alternatively the coupling area can be on the recipient's neck, head, leg or other body part. When the coupler support 200 is in position on the coupling area 280, the elongated portions 221, 222 a and 222 b can flex to conform to the shape of the recipient's body in the coupling area 280. Accordingly, the coupler support 200 can be less likely to be dislodged from the recipient's body and can more accurately align the couplers 260 with the appropriate portions of the coupling area 280.
  • The coupling area 280 includes a plurality of coupling positions or sites 281 (shown as 281 a-j) at which a corresponding plurality of electrode assemblies 230 (shown as 230 a-j) are attached. In one embodiment, the electrode assemblies 230 are arranged in cathode/anode pairs with five circuits formed by electrode assembly pairs 230 a and 230 b; 230 c and 230 d; 230 e and 230 f; 230 g and 230 h; and 230 i and 230 j. Once the coupler support 200 is in position on the recipient's back, each engagement member 240 (shown as 240 a-j) is positioned proximate to its corresponding electrode assembly 230 a-j. For example, those engagement members 240 that are to be coupled with electrode assemblies 230 close to the body longitudinal axis 271 are positioned close to the central axis 270 of the coupler support 200. Those engagement members 240 that are to be coupled with electrode assemblies 230 further away from body longitudinal axis 271 are positioned further away from the central axis 270 of the coupler support 200. Accordingly, many of the couplers 260 are positioned closer to the one corresponding electrode assembly 230 to which that coupler 260 is to be connected than to any other electrode assembly. As a result, practitioners will be less likely to link the couplers 260 to the incorrect electrode assembly 230.
  • FIG. 25 is a top plan view of the coupler support 200 with the couplers 260 removed so that the tops of the engagement members 240 a-j are visible. In one aspect of this embodiment, the engagement members 240 a-j can be marked to indicate which circuit the corresponding couplers 260 are connected to. For example, the engagement members 240 a and 240 b can be marked with a numeral “1” to indicate that the couplers 260 removed from these engagement members are connected to the recipient to form circuit number “1.” An advantage of this arrangement is that if the control unit 62 (FIG. 9) indicates that circuit number “1” is faulty or defective, the practitioner can easily narrow the field of potentially faulty couplers 260 to the two couplers 260 removed from engagement members 240 a and 240 b.
  • In another aspect of this embodiment, the coupler support 200 can include other features to further aid the practitioner in attaching the couplers 260 to the correct coupling site 281. For example, the engagement member 240 a can be can be offset to the right side of the central axis 270 and the engagement member 240 b can be offset to the left side of the central axis 270 so that the practitioner will be more likely to connect the corresponding couplers 260 a, 260 b (FIG. 24) to the appropriate coupling site 281 a, 281 b. In a further aspect of this embodiment, the engagement members 240 a, 240 e, 240 f, 240 i and 240 j positioned on the right side of the central axis 270 can have a different color than the engagement members 240 b, 240 c, 240 d, 240 g and 240 h positioned on the left side of the central axis 270. As is also shown in FIGS. 24 and 25, the overall shape of the coupler support 200, and in particular, an outline defined by the positions of the engagement members 240, is generally similar to an outline defined by the positions of the coupling sites 281. In other embodiments, for example, when the coupler support 200 is configured to rest on the recipient's leg, neck or head for therapy to these regions, the outline defined by the engagement members can also correspond to the outline defined by the coupling sites. In any of these embodiments, the relative longitudinal and lateral locations of the engagement members 240 can correspond at least roughly with the relative longitudinal and lateral locations of the coupling sites 281 on the recipient's body.
  • FIG. 26 is a top isometric view of a portion of a coupler support 300 having a transverse elongated portion 322 a with an engagement member 340 in accordance with another embodiment of the invention. The overall shape of the coupler support 300 can be generally similar to that described above with reference to FIGS. 23-25. In one aspect of this embodiment, the engagement member 340 can include an aperture 341 positioned to receive the housing of a coupler, such as the coupler 260 described above with reference to FIG. 23 or the coupler 60 described above with reference to FIGS. 4-8. In still a further aspect of this embodiment, the engagement member 340 can include a pair of entrance slots 342 positioned to receive the pegs 70 (FIG. 5) of the coupler 60. Once the pegs 70 have been moved into the entrance slots 342, the coupler 60 can be rotated clockwise to move the pegs 70 into transverse locking slots 343. Accordingly, an advantage of this arrangement is that it can securely, yet removably, engage the coupler 60.
  • FIG. 27 is a top isometric view of a portion of a coupler support 400 having a transverse elongated portion 422 a with an engagement member 440 in accordance with another embodiment of the invention. In one aspect of this embodiment, the engagement member 440 can include an aperture 441 configured to receive a clamping coupler 460, such as an alligator clip. The clamping coupler 460 can be attached directly to a percutaneous acupuncture needle 402 or another percutaneous or transcutaneous device. When the clamping coupler 460 is not attached to the needle 402, it can be removably positioned in the aperture 441 while remaining connected to an electrical link 450, such as a cable. In an alternate arrangement shown in FIG. 28, the coupler support 400 can include an engagement member 440 a having a post shape. In one aspect of this embodiment, the clamping coupler 460 can be clamped to the engagement member 440 a to support the coupler 460 relative to the coupler support 400.
  • In one aspect of the embodiments described above with reference to FIGS. 27 and 28, the clamping coupler 460 can be attached to a percutaneous electrode, such as the electrode 102 described above with reference to FIG. 22. Alternatively, the coupler 460 (or other couplers) can be attached to a transcutaneous electrical nerve stimulation system. In still a further embodiment (shown in FIG. 29), a clamping coupler 660 can be clamped to a diagnostic electrode, such as a patch electrode or an EMG needle electrode 630 of the type available from SLE of South Croydon, England. A plurality of the couplers 660 (one of which is shown in FIG. 29) can be connected to a support 600 (shown schematically in FIG. 29) in a configuration generally similar to that described above with reference to FIG. 23 and/or FIG. 11. The support 600 can be connected with a bundled link 651 to a care unit 690. The care unit 690 can include a diagnostic instrument that receives electrical signals from the coupler 660, rather than providing electrical signals to the coupler 660. Accordingly, the support 600 can aid the practitioner in coupling the plurality of couplers 660 to the correct corresponding electrode 630.
  • FIG. 30 is a partially schematic view of a coupler support 700 that can aid the practitioner in delivering medicament to a plurality of coupling sites on the recipient in accordance with another embodiment of the invention. Accordingly, the coupler support 700 can include a plurality of medicament links 750 (one of which is shown in FIG. 30), such as a length of drug delivery tubing. Each link 750 can include a coupler 760 for attaching to a needle or other drug delivery device 730 inserted into the recipient. The individual medicament links 750 can be bundled together to form a bundled link 751 which is connected to a care unit 790. The care unit 790 can include a pump, drip bag, or other arrangement for providing liquid medicament to the coupler support 700 and the recipient.
  • A feature of embodiments of the coupler support arrangements described above with reference to FIGS. 11 and 23-30 is that the supports are configured to position the couplers proximate to the appropriate coupling location. Accordingly, practitioners, including relatively inexperienced practitioners, can be less likely to connect the couplers to an incorrect coupling location. An advantage of this arrangement is that the couplers can provide more reliable and/or more efficacious therapy and/or diagnostic information. A further advantage is that the practitioner can more quickly connect the couplers to the recipient, increasing the efficiency with which the practitioner can provide therapy and/or diagnostic information.
  • Still a further advantage of embodiments of the coupler support described above is that a single support can accommodate a wide variety of applications. For example, a single support can be used with recipients ranging in height from about 4.5 feet to about 6.5 feet, as discussed above. A single coupler support can also be used with recipients having a wide variety of body shapes. Still further, a single coupler support can be positioned on recipients having a variety of postures. For example, a single coupler support can rest on the recipient's back whether the recipient is prone, leaning over, or partially upright, while still allowing the couplers to be connected to the appropriate coupling locations.
  • From the foregoing, it will be appreciated that, although specific embodiments of the invention have been described herein for purposes of illustration, various modifications may be made without deviating from the spirit and scope of the invention. For example, the couplers can be connected directly to the recipient rather than being connected to an intermediate device such as an electrode (i.e., the electrode can be integrated with the coupler). The coupler locations of the support member can include posts or columns, apertures, or any other feature that removably carries the couplers. Accordingly, the invention is not limited except as by the appended claims.

Claims (133)

1. An apparatus for supporting couplers for removable coupling to a recipient during at least one of therapy administration and/or recipient monitoring, the apparatus comprising a support member configured to rest on a body of the recipient, the support member having a first coupler portion configured to be positioned proximate to a first coupling position of the body of the recipient, the support member further having a second coupler portion configured to be positioned proximate to a second coupling position of the body of the recipient, the first coupler portion being configured to removably carry a first coupler, wherein the first coupler is movable relative to the first coupler portion between a first carried position with the first coupler carried by the first coupler portion and a first coupled position with the first coupler operatively coupled to the recipient at the first coupling position the second coupler portion being configured to removably carry a second coupler, wherein the second coupler is movable relative to the second coupler portion between a second carried position with the second coupler carried by the second coupler portion and a second coupled position with the second coupler operatively coupled to the recipient at the second coupling position, the support member being spaced apart from the first and second coupling positions when resting on the body of the recipient.
2. The apparatus of claim 4, further comprising:
a first engagement member depending from the support member at the first coupler portion and configured to removably engage the first coupler; and
a second engagement member depending from the support member at the second coupler portion and configured to removably engage the second coupler.
3. The apparatus of claim 4, further comprising the first and second couplers.
4. An apparatus for supporting couplers for removable coupling to a recipient during at least one of therapy administration and recipient monitoring, the apparatus comprising:
a first coupler having an electrical contact configured to be connected to a percutaneous electrical probe inserted into the recipient;
a support member which aids in placement of the couplers on the recipient, and is configured to rest on a body of the recipient, the support member having a first coupler portion configured to be positioned proximate to a first coupling position of the body of the recipient and a second coupler portion configured to be positioned proximate to a second coupling position of the body of the recipient, the first coupler portion being configured to removably carry the first coupler, the second coupler portion being configured to removably carry a second coupler, the support member being spaced apart from the first and second coupling positions when resting on the body of the recipient; and
a flexible cable connected between the first coupler and the support member, the cable remaining connected between the first coupler and the support member when the first coupler is moved from a first carried position with the first coupler carried by the first coupler portion to a first coupled position with the first coupler operatively coupled to the recipient.
5. The apparatus of claim 4, wherein the first coupler is configured to transmit electrical signals to the recipient when the first coupler is coupled to the recipient at the first coupled position.
6. The apparatus of claim 4 wherein the support member is shaped to rest on at least one of a back, a neck, a head and a leg of the recipient.
7. The apparatus of claim 1 wherein the first and second coupler portions are two of a larger plurality of coupler portions, wherein each of the larger plurality of coupler portions are configured to be positioned proximate to a corresponding one of a larger plurality of coupling positions including the first and second coupling positions, and further wherein an outline of the coupling positions defines a first shape and an outline of the coupler locations defines a corresponding second shape at least generally similar to the first shape.
8. The apparatus of claim 4 wherein the first coupler portion is positioned closer than the second coupler portion to the first coupling position.
9. An apparatus for supporting couplers for removable coupling to a recipient during at least one of therapy administration and recipient monitoring, the apparatus comprising a support member configured to rest on a body of the recipient, the support member being elongated along a support member axis and having a first coupler portion configured to be positioned proximate to a first coupling position of the body of the recipient when the support member rests on the body of the recipient, the support member further having a second coupler portion configured to be positioned proximate to a second coupling position of the body of the recipient when the support member rests on the body of the recipient, the first coupler portion being configured to removably carry a first coupler, wherein the first coupler is movable relative to the first coupler portion between a first carried position with the first coupler carried by the first coupler portion and a first coupled position with the first coupler operatively coupled to the recipient at the first coupling position, the second coupler portion being configured to removably carry a second coupler, wherein the second coupler is movable relative to the second coupler portion between a second carried position with the second coupler carried by the second coupler portion and a second coupled position with the second coupler operatively coupled to the recipient at the second coupling position, the first coupler portion being positioned closer than the second coupler portion to the support member axis.
10. The apparatus of claim 9, further comprising:
a first engagement member depending from the support member at the first coupler portion and configured to removably engage the first coupler; and
a second engagement member depending from the support member at the second coupler portion and configured to removably engage the second coupler.
11. The apparatus of claim 9, further comprising the first and second couplers.
12. The apparatus of claim 9, further comprising:
the first coupler, wherein the first coupler has an electrical contact configured to be connected to a percutaneous electrical probe inserted into the patient; and
a flexible cable connected between the first coupler and the support member, the cable remaining connected between the first coupler and the support member when the first coupler is moved from the first carried position to the first coupled position.
13. The apparatus of claim 9, further comprising the first coupler and wherein the first coupler is configured to transmit electrical signals to the recipient when the first coupler is coupled to the recipient at the first coupling position.
14. The apparatus of claim 9 wherein the support member is shaped to rest on at least one of a back, a neck, a head and a leg of the recipient.
15. The apparatus of claim 9 wherein the first and second coupler portions are two of a larger plurality of coupler portions, wherein each of the larger plurality of coupler portions are configured to be positioned proximate to a corresponding one of a larger plurality of coupling positions including the first and second coupling positions, further wherein an outline of the coupling positions defines a first shape and an outline of the coupler portions defines a corresponding second shape at least generally similar to the first shape.
16. An apparatus for supporting couplers for removable coupling to a recipient during at least one of therapy administration and recipient monitoring, the apparatus comprising a support member configured to rest on a body of the recipient, the support member having a first coupler portion configured to be positioned proximate to a first coupling position of the body of the recipient, the support member further having a second coupler portion configured to be positioned proximate to a second coupling position of the body of the recipient, the first coupler portion being configured to removably carry a first coupler, wherein the first coupler is movable relative to the first coupler portion between a first carried position with the first coupler carried by the first coupler portion and a first coupled position with the first coupler operatively coupled to the recipient at the first coupling position the second coupler location being configured to removably carry a second coupler, wherein the second coupler is movable relative to the second coupler portion between a second carried position with the second coupler carried by the second coupler portion and a second coupled position with the second coupler operatively coupled to the recipient at the second coupling position, the first coupler portion configured to be positioned closer than the second coupler portion to the first coupling position of the body of the recipient.
17. The apparatus of claim 16, further comprising:
a first engagement member depending from the support member at the first coupler portion and configured to removably engage the first coupler; and
a second engagement member depending from the support member at the second coupler portion and configured to removably engage the second coupler.
18. The apparatus of claim 16, further comprising the first and second couplers.
19. The apparatus of claim 16, further comprising:
the first coupler, wherein the first coupler has an electrical contact configured to be connected to a percutaneous electrical probe inserted into the patient; and
a flexible cable connected between the first coupler and the support member, the cable remaining connected between the first coupler and the support member when the first coupler is moved from the first carried position to the first coupled position.
20. The apparatus of claim 16, further comprising the first coupler and wherein the first coupler is configured to receive electrical signals from the recipient when the first coupler is coupled to the recipient at the first coupling position.
21. The apparatus of claim 16, further comprising the first coupler, and wherein the first coupler is configured to provide liquid medicament to the recipient when the first coupler is coupled to the recipient at the first coupling position.
22. The apparatus of claim 16, further comprising the first coupler and wherein the first coupler is configured to transmit electrical signals to the recipient when the first coupler is coupled to the recipient at the first coupling position.
23. An apparatus for supporting couplers for removable coupling to a recipient during at least one of therapy administration and recipient monitoring, the apparatus comprising:
a support member which aids in placement of the couplers on the recipient, and is configured to rest on a body of the recipient, the support member having a first coupler portion configured to be positioned proximate to a first coupling position of the body of the recipient and a second coupler portion configured to be positioned proximate to a second coupling position of the body of the recipient, the first coupler portion being configured to removably carry a first coupler, the second coupler portion being configured to removably carry a second coupler, the first coupler portion configured to be positioned closer than the second coupler portion to the first coupling position of the body of the recipient; wherein the support member includes a cavity at the first coupler portion positioned to receive at least a portion of the first coupler.
24. The apparatus of claim 4 wherein the support member includes a column at the first coupler portion positioned to be received in an aperture of the first coupler.
25. The apparatus of claim 16 wherein the support member is shaped to rest on at least one of a back, a neck, a head and a leg of the recipient.
26. The apparatus of claim 16 wherein the first and second coupler portions are two of a larger plurality of coupler portions, wherein each of the larger plurality of coupler portions are configured to be positioned proximate to a corresponding one of a larger plurality of coupling positions including the first and second coupling positions, further wherein an outline of the coupling positions defines a first shape and an outline of the coupler locations defines a corresponding second shape at least generally similar to the first shape.
27. An apparatus for supporting couplers for removable coupling to a recipient during at least one therapy administration and recipient monitoring, the apparatus comprising:
a support member configured to rest on a body of the recipient proximate to a coupling region, the support member having a first engagement portion configured to be positioned proximate to a first coupling position on the body of the recipient and a second engagement portion configured to be positioned proximate to a second coupling position on the body of the recipient;
a first engagement member configured to removably carry a first coupler at the first engagement portion of the support member, wherein the first coupler is movable relative to the first coupler portion between a first attached position with the first coupler carried by the first engagement member and a first coupled position with the first coupler operatively coupled to the recipient at the first coupling position; and
a second engagement member configured to removably carry a second coupler at the second engagement portion of the support member, wherein the second coupler is movable relative to the second coupler portion between a second attached position with the second coupler carried by the second engagement member and a second coupled position with the second coupler operatively coupled to the recipient at the second coupling position, the first engagement member configured to be positioned closer than the second engagement member to the first coupling position.
28. An apparatus for supporting couplers for removable coupling to a recipient during at least one of therapy administration and recipient monitoring, the apparatus comprising:
a first coupler having an electrical contact configured to be connected to a percutaneous electrical probe inserted into the recipient;
a support member which aids in placement of the couplers on the recipient, and is configured to rest on a body of the recipient proximate to a coupling region, the support member having a first engagement portion configured to be positioned proximate to a first coupling position on the body of the recipient and a second engagement portion configured to be positioned proximate to a second coupling position on the body of the recipient;
a first engagement member configured to removably carry the first coupler at the first engagement portion of the support member;
a second engagement member configured to removably carry a second coupler at the second engagement portion of the support member, the first engagement member configured to be positioned closer than the second engagement member to the first coupling position; and
a flexible cable connected between the first coupler and the support member, the cable remaining connected between the first coupler and the support member when the first coupler is moved from a first attached position with the first coupler carried by the first engagement member to a first coupled position with the first coupler operatively coupled to the recipient.
29. An apparatus for supporting couplers for removable coupling to a recipient monitoring, the apparatus comprising:
a support member configured to rest on a body of the recipient proximate to a coupling region, the support member having a first engagement portion configured to a be positioned proximate to a first coupling position on the body of ht recipient and a second engagement portion configured to be positioned proximate to a second coupling position on the body of the recipient;
a first engagement member configured to removably carry a first coupler at the first engagement portion of the support member; and
a second engagement member configured to removably carry a second coupler at the second engagement portion of the support member, the first engagement member configured to be positioned closer than the second engagement member to the first coupling position
wherein the support member has a central axis, a first elongated portion positioned along the central axis, a second elongated portion extending transversely to the central axis on first and second sides of the central axis, and a third elongated portion positioned between the first and second elongated portions and extending transversely to the central axis on the first and second sides of the central axis, further wherein the first and second engagement members are positioned on one of the elongated portions, with the first engagement member including a first post positioned on the first side of the central axis and the second engagement member including second a post positioned on the second side of the central axis.
30. The apparatus of claim 27 wherein the first coupler is configured to receive electrical signals from the recipient when the first coupler is coupled to the recipient at the first coupling position.
31. The apparatus of claim 27 wherein the first coupler is configured to provide liquid medicament to the recipient when the first coupler is coupled to the recipient at the first coupling position.
32. An apparatus for supporting couplers for removable coupling to a recipient during at least one of therapy administration and recipient monitoring, the apparatus comprising:
a first coupler;
a support member which aids in placement of the couplers on the recipient, and is configured to rest on a body of the recipient proximate to a coupling region, the support member having a first engagement portion configured to be positioned proximate to a first coupling position on the body of the recipient and a second engagement portion configured to be positioned proximate to a second coupling position on the body of the recipient;
a first engagement member configured to removably carry the first coupler at the first engagement portion of the support member;
a second engagement member configured to removably carry a second coupler at the second engagement portion of the support member, the first engagement member configured to be positioned closer than the second engagement member to the first coupling position; and
a flexible link connected between the first coupler and the support member, the link remaining connected between the first coupler and the support member when the first coupler is moved from the first attached position to the first coupled position.
33. The apparatus of claim 32 wherein the link includes an electrical cable configured to be coupled to a source of electrical pulses to transmit percutaneous electrical stimulation pulses to the first coupler.
34. The apparatus of claim 32 wherein the link includes an electrical cable configured to be coupled to a signal monitor to monitor electrical signals received at the first coupler from the recipient.
35. The apparatus of claim 32 wherein the link includes a length of tubing configured to be coupled to a source of liquid medicament.
36. The apparatus of claim 28 wherein the first engagement member includes a column projecting away from the support member, the column configured to be received in an aperture of the first coupler.
37. The apparatus of claim 28 wherein the support member is flexible and resilient to conform to a surface of the body.
38. The apparatus of claim 28 wherein the support member is shaped to rest on at least one of a back, a neck, a head and a leg of the recipient.
39. An apparatus for supporting couplers for removable coupling to a recipient during at least one of therapy administrations and recipient monitoring, the apparatus comprising:
a support member which aids in placement of the couplers on the recipient, and is configured to reset on a body of the recipient proximate to a coupling region, the support member having a first engagement portion configured to be positioned proximate to a first coupling position on the body of the recipient and a second engagement portion configured to be positioned proximate to a second coupling position on the body of the recipient;
a first engagement member configured to removably carry a first coupler at the first engagement portion of the support member; and
a second engagement member configured to removably carry a second coupler at the second engagement portion of the support member, the first engagement member configured to be position closer than the second engagement member to the first coupling position;
wherein the first engagement member has a cavity positioned to receive at least a portion of the first coupler.
40. The apparatus of claim 28 wherein an arrangement of the first and second engagement members corresponds at least approximately to an arrangement of the first and second coupling positions.
41. The apparatus of claim 27 wherein the first and second engagement members are two of a larger plurality of engagement members, wherein each of the larger plurality of engagement members are configured to be positioned proximate to a corresponding one of a larger plurality of coupling positions including the first and second coupling positions, further wherein an outline of the coupling positions defines a first shape and an outline of the engagement members defines a corresponding second shape at least generally similar to the first shape.
42. The apparatus of claim 28 wherein the first and second coupling positions are two of a larger plurality of coupling positions located on first and second sides of a central axis of the support member, and wherein the first and second engagement members are two of a larger plurality of engagement members arranged in two rows on opposite sides of the central axis.
43. The apparatus of claim 28 wherein the first and second coupling positions each have a longitudinal location along a body longitudinal axis and a lateral location transverse to the body longitudinal axis, and wherein the support member has a central support member axis generally aligned with the body longitudinal axis during operation, further wherein the first engagement member has a longitudinal location and a lateral location relative to the central support member axis that correspond to the longitudinal and lateral locations of the first coupling position relative to the body longitudinal axis, still further wherein the second engagement member has a longitudinal location and a lateral location relative to the central support member axis that correspond to the longitudinal and lateral locations of the second coupling position relative to the body longitudinal axis.
44. The apparatus of claim 28, further comprising the first and second couplers.
45. The apparatus of claim 28 wherein at least a portion of the first engagement member has a first color and at least a portion of the second engagement member has a second color different than the first color.
46. The apparatus of claim 28 wherein the first engagement member has a visual indicator corresponding to the first coupling position.
47. An apparatus for supporting couplers for removable coupling to a recipient during at least one of therapy administration and recipient monitoring, the apparatus comprising:
a support member which aids in placement of the couplers on the recipient, and is configured to rest on a body of the recipient proximate to a coupling region, the support member having a first engagement portion configured to be positioned proximate to a first coupling position on the body of the recipient and a second engagement portion configured to be positioned proximate to a second coupling position on the body of the recipient;
a first engagement member configured to removably carry a first coupler at the first engagement position of the support member;
a second engagement member configured to removably carry a second coupler at the second engagement portion of the support member, the first engagement member configured to be positioned closer than the second engagement member to the first coupling position; and
the first coupler, wherein the first coupler includes an electrical connector positioned for making electrical contact with a percutaneous probe at the first coupling position.
48. The apparatus of claim 28 wherein the support member includes a flexible, bio-compatible material.
49. An apparatus for supporting couplers for removable coupling to a recipient during at least one of therapy administration and recipient monitoring, the apparatus comprising:
a support member which aids in the placement of the couplers on the recipient, and is configured to rest on a body of the recipient proximate to a coupling region the support member having a first engagement portion configured to be positioned proximate to a first coupling position on the body of the recipient and a second engagement portion configured be positioned proximate to a second coupling position on the body of the recipient;
a first engagement member configured to removably carry a first coupler at the first engagement portion of the support member; and
a second engagement member configured to removably carry a second coupler at the second engagement portion of the support member, the first engagement member configured to be positioned closer than the second engagement member to the first coupling position
wherein the support member includes a generally flat, rigid material.
50. The apparatus of claim 28 wherein the first coupler includes an electrically conductive clamp, and wherein the first engagement member is configured to carry the first coupler including the electrically conductive clamp.
51. The apparatus of claim 28 wherein the first coupler includes an electrically conductive alligator clip, and wherein the first engagement member is configured to carry the first coupler including the electrically conductive alligator clip.
52. (canceled)
53. An apparatus for supporting a plurality of percutaneous probe couplers in position for removable coupling to a recipient, comprising:
a flexible support member which aids in placement of the couplers on the recipient, and is configured to rest on a body of a recipient and conform to a curvature of the body proximate to a location where the couplers are to be coupled to the body;
a first engagement member depending from the support member and configured to be positioned proximate to a first coupling position on the body;
a first coupler removably engaged with the first engagement member;
a first electrical cable attached between the first coupler and the support member;
a second engagement member depending from the support member body and configured to be positioned proximate to a second coupling position on the body of the recipient, the first engagement member configured to be positioned closer than the second engagement member to the first coupling position, the second engagement member configured to be positioned closer than the first engagement member to the second coupling position;
a second coupler removably engaged with the second engagement member; and
a second electrical cable attached between the second coupler and the support member.
54. The apparatus of claim 53 wherein the first electrical cable is attached to the support member at a first attachment location, and the second electrical cable is attached to the support member at a second attachment location, and further wherein the first and second electrical cables are bundled together within the support member and exit the support member adjacent to each other at a third attachment location.
55. (canceled)
56. The apparatus of claim 53 wherein the first coupler includes an electrically conductive clamp.
57. The apparatus of claim 53 wherein the first coupler includes an electrically conductive alligator clip.
58. The apparatus of claim 53 wherein the first and second electrical cables have approximately the same length.
59. The apparatus of claim 53 wherein the first electrical cable has a first length and the second electrical cable has a second length different than the first length.
60. (canceled)
61. The apparatus of claim 53 wherein the first coupler has an aperture and wherein the first engagement member includes a column projecting away from the support member and positioned to be received in the aperture of the first coupler.
62. The apparatus of claim 53 wherein the support member is shaped to rest on at least one of a back, a neck, a head and a leg of the recipient.
63. The apparatus of claim 53 wherein an arrangement of the first and second engagement members corresponds at least approximately to an arrangement of the first and second coupling positions.
64. The apparatus of claim 53 wherein the first and second engagement members are two of a larger plurality of engagement members, wherein each of the larger plurality of engagement members are configured to be positioned proximate to a corresponding one of a larger plurality of coupling positions including the first and second coupling positions, further wherein an outline of the coupling positions defines a first shape and an outline of the engagement members defines a corresponding second shape at least generally similar to the first shape.
65. An apparatus for supporting a plurality of percutaneous probe couplers in position for removable coupling to a recipient, comprising:
a flexible support member which aids in placement of the couplers on the recipient, and is configured to rest on a body of a recipient and conform to a curvature of the body proximate to a coupling location where the couplers are to be coupled to the body, the support member having a central axis;
a first engagement member depending from the support member and positioned on a first side of the central axis, the first engagement member configured to be positioned proximate to a first coupling position on the body of the recipient, the first coupling position located on the first side of the central axis;
a first coupler removably engaged with the first engagement member;
a first electrical cable attached between the first coupler and the support member;
a second engagement member depending from the support member and positioned on a second side of the central axis opposite the first side of the central axis, the second engagement member configured to be positioned proximate to a second coupling position on the body of the recipient, the second coupling position located on the second side of the central axis;
a second coupler removably engaged with the second engagement member; and
a second electrical cable attached between the second coupler and the support member.
66. The apparatus of claim 65 wherein the first electrical cable is attached to the support member at a first attachment location, and the second electrical cable is attached to the support member at a second attachment location, and further wherein the first and second electrical cables are bundled together within the support member and exit the support member adjacent to each other at a third attachment location.
67. (canceled)
68. The apparatus of claim 65 wherein the first coupler includes an electrically conductive clamp.
69. The apparatus of claim 65 wherein the first coupler includes an electrically conductive alligator clip.
70. The apparatus of claim 65 wherein the first and second electrical cables have approximately the same length.
71. The apparatus of claim 65 wherein the first electrical cable has a first length and the second electrical cable has a second length different than the first length.
72. (canceled)
73. The apparatus of claim 65 wherein the first coupler has an aperture and wherein the first engagement member includes a post projecting away from the support member and positioned to be received in the aperture of the first coupler.
74. The apparatus of claim 65 wherein the support member is shaped to rest on at least one of a back, a neck, a head and a leg of the recipient.
75. The apparatus of claim 65 wherein an arrangement of the first and second engagement members corresponds at least approximately to an arrangement of the first and second coupling positions.
76. The apparatus of claim 65 wherein the first and second engagement members are two of a larger plurality of engagement members, wherein each of the larger plurality of engagement members are configured to be positioned proximate to a corresponding one of a larger plurality of coupling positions including the first and second coupling positions, further wherein an outline of the coupling positions defines a first shape and an outline of the engagement members defines a corresponding second shape at least generally similar to the first shape.
77. (canceled)
78. (canceled)
79. (canceled)
80. (canceled)
81. (canceled)
82. (canceled)
83. An apparatus for supporting couplers for removable coupling to a recipient during at least one of therapy administration and recipient monitoring, the apparatus comprising:
support member which aids in placement of the couplers on the recipient, and is configured to rest on a body of the recipient, the support member having a first coupler portion configured to be positioned proximate to a first coupling position of the body of the recipient, the support member further having a second coupler portion configured to be positioned proximate to a second coupling position of the body of the recipient, the first coupler portion configured to be positioned closer than the second coupler portion to the first coupling position on the body of the recipient;
a first coupler configured to be operatively coupled to the body when spaced apart from the first coupler portion and configured to be removably supported at the first coupler portion;
a second coupler configured to be operatively coupled to the body when spaced apart from the second coupler portion and configured to be removably supported at the second-coupler portion;
a recipient care unit configured to deliver therapy, monitor a condition of the recipient, or delivery therapy and monitor a condition of the recipient; and
a first link between the care unit and the first coupler and a second link between the care unit and the second coupler.
84. (Canceled).
85. The apparatus of claim 83 wherein the recipient care unit includes a source of medicament.
86. The apparatus of claim 83 wherein the recipient care unit includes a monitor of electrical signals.
87. An apparatus for supporting couplers for removable coupling to a recipient during at least one of therapy administration and recipient monitoring, the apparatus comprising:
a support member which aids in placement of the couplers on the recipient, and is configured to rest on a body of the recipient, the support member having a first coupler portion configured to be positioned proximate to a first coupling position of the body of the recipient, the support member further having a second coupler portion configured to be positioned proximate to a second coupling position of the body of the recipient, the first coupler portion configured to be positioned closer than the second coupler portion to the first coupling position on the body of the recipient;
a first coupler configured to be operatively coupled to the body and removably supported at the first coupler portion;
a second coupler configured to be operatively coupled to the body and removably supported at the second coupler portion;
a recipient care unit configured to deliver therapy monitor a condition of the recipient, or delivery therapy and monitor a condition of the recipient; and
a first link between the care unit and the first coupler and second link between the care unit and the second coupler;
wherein the first coupler is moveable relative to the support member between an attached position with the first coupler engaged with the support member at the first coupler location, a detached position with the first coupler disengaged from the first coupler location, and a coupled position with the first coupler operatively coupled to the recipient at the first coupling position, the first coupler having an electrical contact for connecting to a percutaneous electrical probe inserted into the patient, and further wherein the first link includes a flexible electrical cable.
88. (canceled)
89. The apparatus of claim 83 wherein the first coupler has an aperture and wherein the support member includes a post at the first coupler location positioned to be received in the aperture of the first coupler.
90. The apparatus of claim 83 wherein the support member is flexible and resilient to conform to a surface of the body.
91. The apparatus of claim 83 wherein the support member is shaped to rest on at least one of a back, a neck, a head and a leg of the recipient.
92. The apparatus of claim 83 wherein an arrangement of the first and second coupler locations corresponds at least approximately to an arrangement of the first and second coupling positions.
93. The apparatus of claim 83 wherein the first and second coupler portions are two of a larger plurality of coupler portions, wherein each of the larger plurality of coupler portions are configured to be positioned proximate to a corresponding one of a larger plurality of coupling positions including the first and second coupling positions, further wherein an outline of the coupling positions defines a first shape and an outline of the coupler locations defines a corresponding second shape at least generally similar to the first shape.
94. A method for coupling therapy and/or monitoring equipment to a recipient, comprising:
positioning a support member against a body of a recipient proximate to a coupling area of the body and spaced apart from first and second coupling positions in the coupling area;
supporting a first coupler relative to the body at a first coupler location of the support member proximate to the first coupling position;
supporting a second coupler relative to the body at a second coupler location of the support member proximate to the second coupling position;
removing the first coupler from the first coupler location of the support member and coupling the first coupler to the body at the first coupling position; and
removing the second coupler from the second coupler location of the support member and coupling the second coupler to the body at the second coupling position.
95. The method of claim 94 wherein positioning the support member includes positioning a first elongated portion of the support member along a longitudinal axis of the coupling area, positioning a second elongated portion of the support member transverse to the longitudinal axis, and positioning a third elongated portion of the support member transverse to the longitudinal axis between the first and second elongated portions.
96. The method of claim 94 wherein coupling the first coupler to the body includes electrically coupling the first coupler to the body, and wherein the method further includes transmitting electrical signals to the body.
97. The method of claim 94 wherein supporting the first coupler includes supporting the first coupler closer than the second coupler to the first coupling position.
98. The method of claim 94, further comprising conforming the support member to a curved surface of the body.
99. The method of claim 94 wherein positioning the support member against the body includes positioning the support member against at least one of a back, a neck, a head and a leg of the recipient.
100. The method of claim 94 wherein the first and second coupling positions are two of a larger plurality of coupling positions and the first and second coupler locations are two of a larger plurality of coupler locations and wherein the method further comprises orienting the support member with an outline of the coupler locations being generally similar to an outline defined by the coupling positions.
101. The method of claim 94 wherein coupling the first coupler includes coupling the first coupler to a percutaneous probe at the first coupling position.
102. A method for coupling therapy and/or monitoring equipment to a recipient, comprising:
positioning a support member against a body of a recipient proximate to a coupling area of the body, the support member being elongated along a support member axis;
supporting a first coupler relative to the body at a first coupler location of the support member proximate to a first coupling position of the body;
supporting a second coupler relative to the body at a second coupler location of the support member proximate to a second coupling position of the body with the first coupler positioned closer than the second coupler to the support member axis;
removing the first coupler from the first coupler location of the support member and coupling the first coupler to the body at the first coupling position; and
removing the second coupler from the second coupler location of the support member and coupling the second coupler to the body at the second coupling position.
103. The method of claim 102 wherein positioning the support member includes positioning a first elongated portion of the support member along a longitudinal axis of the coupling area, positioning a second elongated portion of the support member transverse to the longitudinal axis, and positioning a third elongated portion of the support member transverse to the longitudinal axis between the first and second elongated portions.
104. The method of claim 102 wherein coupling the first coupler to the body includes electrically coupling the first coupler to the body, and wherein the method further includes transmitting electrical signals to the body.
105. The method of claim 102 wherein supporting the first coupler includes supporting the first coupler closer than the second coupler to the first coupling position.
106. The method of claim 102, further comprising conforming the support member to a curved surface of the body.
107. The method of claim 102 wherein positioning the support member against the body includes positioning the support member against at least one of a back, a neck, a head and a leg of the recipient.
108. The method of claim 102 wherein the first and second coupling positions are two of a larger plurality of coupling positions and the first and second coupler locations are two of a larger plurality of coupler locations and wherein the method further comprises orienting the support member with an outline of the coupler locations being generally similar to an outline defined by the coupling positions.
109. The method of claim 102 wherein coupling the first coupler includes coupling the first coupler to a percutaneous probe at the first coupling position.
110. A method for coupling therapy and/or monitoring equipment to a recipient, comprising:
positioning a support member against a body of a recipient proximate to a coupling area;
supporting a first coupler relative to the body at a first coupler location of the support member proximate to a first coupling position on the body;
supporting a second coupler relative to the body at a second coupler location of the support member proximate to a second coupling position on the body, the first coupler location being positioned closer than the second coupler location to the first coupling position;
removing the first coupler from the first coupler location of the support member and coupling the first coupler to the body at the first coupling position; and
removing the second coupler from the second coupler location of the support member and coupling the second coupler to the body at the second coupling position.
111. The method of claim 110 wherein positioning the support member includes positioning a first elongated portion of the support member along a longitudinal axis of the coupling area, positioning a second elongated portion of the support member transverse to the longitudinal axis, and positioning a third elongated portion of the support member transverse to the longitudinal axis between the first and second elongated portions.
112. The method of claim 110 wherein coupling the first coupler to the body includes electrically coupling the first coupler to the body, and wherein the method further includes transmitting electrical signals to the body.
113. The method of claim 110 wherein coupling the first coupler to the body includes electrically coupling the first coupler to the body, and wherein the method further includes receiving electrical signals from the body.
114. The method of claim 110 wherein the first coupler is configured to provide liquid medicament to the recipient and wherein the method further comprises delivering liquid medicament to the first coupler and the recipient when the first coupler is coupled to the recipient at the first coupling position.
115. The method of claim 110 wherein removing the first coupler includes removing the first coupler from an aperture of the support member.
116. The method of claim 110 wherein removing the first coupler includes removing the first coupler from a post of the support member.
117. The method of claim 110, further comprising conforming the support member to a curved surface of the body.
118. The method of claim 110 wherein positioning the support member against the body includes positioning the support member against at least one of a back, a neck, a head and a leg of the recipient.
119. The method of claim 110 wherein positioning the support member includes orienting the support member with an arrangement of the first and second coupler locations corresponding at least approximately to an arrangement of the first and second coupling positions.
120. The method of claim 110 wherein the first and second coupling positions are two of a larger plurality of coupling positions and the first and second coupler locations are two of a larger plurality of coupler locations and wherein the method further comprises orienting the support member with an outline of the coupler locations being generally similar to an outline defined by the coupling positions.
121. The method of claim 110 wherein coupling the first coupler includes coupling the first coupler to a percutaneous probe at the first coupling position.
122. The method of claim 110 wherein coupling the first coupler includes clamping the first coupler to a percutaneous electrode inserted in the recipient.
123. A method for administering percutaneous electrical therapy to a recipient, comprising:
aligning a flexible support member with a body of a recipient;
positioning the support member against the body proximate to a coupling area;
conforming the support member to a curvature of the body
supporting a first coupler relative to the body at a first coupler location of the support member proximate to a first coupling position of the body;
supporting a second coupler relative to the body at a second coupler location of the support member proximate to a second coupling position of the body with the first coupler location positioned closer than the second coupler location to the first coupling position;
removing the first coupler from the first coupler location of the support member and electrically coupling the first coupler to a first percutaneous probe positioned in the body at the first coupling position;
removing the second coupler from the second coupler location of the support member and electrically coupling the second coupler to a second percutaneous probe in the body at the second coupling position; and
electrically coupling the first and second couplers to a source of electrical potential.
124. The method of claim 123, further comprising actuating the first coupler to insert the first percutaneous probe in the recipient.
125. The apparatus of claim 123 wherein the support member has a central axis, a first elongated portion positioned along the central axis, a second elongated portion extending transversely to the central axis on first and second sides of the central axis, and a third elongated portion positioned between the first and second elongated portions and extending transversely to the central axis on the first and second sides of the central axis, further wherein the first and second coupler locations are positioned on one of the elongated portions, with the support member including a post positioned at the first coupler location on the first side of the central axis and the support member further including a post positioned at the second coupler location on the second side of the central axis.
126. The method of claim 123 wherein the first coupler has an aperture and wherein removing the first coupler includes disengaging the aperture with a post of the support member.
127. The method of claim 123, further comprising resting the support member on at least one of a back, a neck, a head and a leg of the recipient.
128. The method of claim 123, further comprising orienting the support member with an arrangement of the first and second coupler locations corresponding at least approximately to an arrangement of the first and second coupling positions.
129. A method for administering percutaneous electrical therapy to a recipient, comprising:
aligning a flexible support member with a body of a recipient by aligning a first elongated portion of the support member with a spine of the recipient and positioning second and third elongated portions of the support member transverse to the spine;
conforming the support member to the body proximate to a coupling area;
removing five pairs of electrical couplers from the support member and connecting the electrical couplers to percutaneous probes inserted into the recipient while the electrical couplers remain connected to the support member with electrical cables, wherein removing the five pairs of electrical couplers includes removing couplers of a first pair positioned toward an end of the first elongated portion, removing couplers of a second pair positioned at opposite ends of the second elongated portion, removing couplers of a third pair positioned at opposite ends of the third elongated portion, removing couplers of a fourth pair positioned between the first and second pair, and removing couplers of a fifth pair positioned between the second and third pair; and
electrically connecting each coupler to an electrically conductive percutaneous probe inserted in the body.
130. The method of claim 129, further comprising electrically coupling each coupler to a source of electrical potential.
131. The apparatus of claim 4 wherein the support member is elongated along a support member axis.
132. The apparatus of claim 4, further comprising:
a first engagement member depending from the support member at the first coupler portion and configured to removably engage the first coupler; and
a second engagement member depending from the support member at the second coupler portion and configured to removably engage the second coupler.
133. The apparatus of claim 4, further comprising the second coupler.
US10/994,372 1999-12-01 2004-11-23 Apparatus and method for coupling therapeutic and/or monitoring equipment to a patient Abandoned US20050096717A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/994,372 US20050096717A1 (en) 1999-12-01 2004-11-23 Apparatus and method for coupling therapeutic and/or monitoring equipment to a patient

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/452,477 US6622051B1 (en) 1999-12-01 1999-12-01 Percutaneous electrical therapy system with electrode entry angle control
US09/666,931 US6529776B1 (en) 1999-12-01 2000-09-21 Method and apparatus for repositioning a percutaneous probe
US09/751,382 US6912424B2 (en) 1999-12-01 2000-12-29 Apparatus and method for coupling therapeutic and/or monitoring equipment to a patient
US10/994,372 US20050096717A1 (en) 1999-12-01 2004-11-23 Apparatus and method for coupling therapeutic and/or monitoring equipment to a patient

Related Parent Applications (3)

Application Number Title Priority Date Filing Date
US09/452,477 Continuation-In-Part US6622051B1 (en) 1999-12-01 1999-12-01 Percutaneous electrical therapy system with electrode entry angle control
US09/666,931 Continuation-In-Part US6529776B1 (en) 1999-12-01 2000-09-21 Method and apparatus for repositioning a percutaneous probe
US09/751,382 Continuation US6912424B2 (en) 1999-12-01 2000-12-29 Apparatus and method for coupling therapeutic and/or monitoring equipment to a patient

Publications (1)

Publication Number Publication Date
US20050096717A1 true US20050096717A1 (en) 2005-05-05

Family

ID=27036785

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/751,382 Expired - Fee Related US6912424B2 (en) 1999-12-01 2000-12-29 Apparatus and method for coupling therapeutic and/or monitoring equipment to a patient
US10/994,372 Abandoned US20050096717A1 (en) 1999-12-01 2004-11-23 Apparatus and method for coupling therapeutic and/or monitoring equipment to a patient

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/751,382 Expired - Fee Related US6912424B2 (en) 1999-12-01 2000-12-29 Apparatus and method for coupling therapeutic and/or monitoring equipment to a patient

Country Status (1)

Country Link
US (2) US6912424B2 (en)

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8613708B2 (en) 2010-10-08 2013-12-24 Cardiac Science Corporation Ambulatory electrocardiographic monitor with jumpered sensing electrode
US8613709B2 (en) 2010-10-08 2013-12-24 Cardiac Science Corporation Ambulatory electrocardiographic monitor for providing ease of use in women
US8626277B2 (en) 2010-10-08 2014-01-07 Cardiac Science Corporation Computer-implemented electrocardiographic data processor with time stamp correlation
USD717955S1 (en) 2013-11-07 2014-11-18 Bardy Diagnostics, Inc. Electrocardiography monitor
US9037477B2 (en) 2010-10-08 2015-05-19 Cardiac Science Corporation Computer-implemented system and method for evaluating ambulatory electrocardiographic monitoring of cardiac rhythm disorders
US20150223894A1 (en) * 2014-02-09 2015-08-13 John E Burbank Neuromonitoring needle-cartridge gun system
USD744659S1 (en) 2013-11-07 2015-12-01 Bardy Diagnostics, Inc. Extended wear electrode patch
CN105556602A (en) * 2013-08-29 2016-05-04 杜比国际公司 Frequency band table design for high frequency reconstruction algorithms
US9345414B1 (en) 2013-09-25 2016-05-24 Bardy Diagnostics, Inc. Method for providing dynamic gain over electrocardiographic data with the aid of a digital computer
US9364155B2 (en) 2013-09-25 2016-06-14 Bardy Diagnostics, Inc. Self-contained personal air flow sensing monitor
US9408551B2 (en) 2013-11-14 2016-08-09 Bardy Diagnostics, Inc. System and method for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer
US9408545B2 (en) 2013-09-25 2016-08-09 Bardy Diagnostics, Inc. Method for efficiently encoding and compressing ECG data optimized for use in an ambulatory ECG monitor
US9433380B1 (en) 2013-09-25 2016-09-06 Bardy Diagnostics, Inc. Extended wear electrocardiography patch
US9433367B2 (en) 2013-09-25 2016-09-06 Bardy Diagnostics, Inc. Remote interfacing of extended wear electrocardiography and physiological sensor monitor
USD766447S1 (en) 2015-09-10 2016-09-13 Bardy Diagnostics, Inc. Extended wear electrode patch
US9504423B1 (en) 2015-10-05 2016-11-29 Bardy Diagnostics, Inc. Method for addressing medical conditions through a wearable health monitor with the aid of a digital computer
US9545204B2 (en) 2013-09-25 2017-01-17 Bardy Diagnostics, Inc. Extended wear electrocardiography patch
US9615763B2 (en) 2013-09-25 2017-04-11 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitor recorder optimized for capturing low amplitude cardiac action potential propagation
US9619660B1 (en) 2013-09-25 2017-04-11 Bardy Diagnostics, Inc. Computer-implemented system for secure physiological data collection and processing
US9655538B2 (en) 2013-09-25 2017-05-23 Bardy Diagnostics, Inc. Self-authenticating electrocardiography monitoring circuit
US9655537B2 (en) 2013-09-25 2017-05-23 Bardy Diagnostics, Inc. Wearable electrocardiography and physiology monitoring ensemble
US9700227B2 (en) 2013-09-25 2017-07-11 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation
USD793566S1 (en) 2015-09-10 2017-08-01 Bardy Diagnostics, Inc. Extended wear electrode patch
US9717433B2 (en) 2013-09-25 2017-08-01 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation
US9717432B2 (en) 2013-09-25 2017-08-01 Bardy Diagnostics, Inc. Extended wear electrocardiography patch using interlaced wire electrodes
US9737224B2 (en) 2013-09-25 2017-08-22 Bardy Diagnostics, Inc. Event alerting through actigraphy embedded within electrocardiographic data
US9775536B2 (en) 2013-09-25 2017-10-03 Bardy Diagnostics, Inc. Method for constructing a stress-pliant physiological electrode assembly
USD801528S1 (en) 2013-11-07 2017-10-31 Bardy Diagnostics, Inc. Electrocardiography monitor
USD831833S1 (en) 2013-11-07 2018-10-23 Bardy Diagnostics, Inc. Extended wear electrode patch
US10165946B2 (en) 2013-09-25 2019-01-01 Bardy Diagnostics, Inc. Computer-implemented system and method for providing a personal mobile device-triggered medical intervention
US10251576B2 (en) 2013-09-25 2019-04-09 Bardy Diagnostics, Inc. System and method for ECG data classification for use in facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer
US10433748B2 (en) 2013-09-25 2019-10-08 Bardy Diagnostics, Inc. Extended wear electrocardiography and physiological sensor monitor
US10433751B2 (en) 2013-09-25 2019-10-08 Bardy Diagnostics, Inc. System and method for facilitating a cardiac rhythm disorder diagnosis based on subcutaneous cardiac monitoring data
US10463269B2 (en) 2013-09-25 2019-11-05 Bardy Diagnostics, Inc. System and method for machine-learning-based atrial fibrillation detection
US10624551B2 (en) 2013-09-25 2020-04-21 Bardy Diagnostics, Inc. Insertable cardiac monitor for use in performing long term electrocardiographic monitoring
US10667711B1 (en) 2013-09-25 2020-06-02 Bardy Diagnostics, Inc. Contact-activated extended wear electrocardiography and physiological sensor monitor recorder
USD892340S1 (en) 2013-11-07 2020-08-04 Bardy Diagnostics, Inc. Extended wear electrode patch
US10736531B2 (en) 2013-09-25 2020-08-11 Bardy Diagnostics, Inc. Subcutaneous insertable cardiac monitor optimized for long term, low amplitude electrocardiographic data collection
US10736529B2 (en) 2013-09-25 2020-08-11 Bardy Diagnostics, Inc. Subcutaneous insertable electrocardiography monitor
US10799137B2 (en) 2013-09-25 2020-10-13 Bardy Diagnostics, Inc. System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer
US10806360B2 (en) 2013-09-25 2020-10-20 Bardy Diagnostics, Inc. Extended wear ambulatory electrocardiography and physiological sensor monitor
US10820801B2 (en) 2013-09-25 2020-11-03 Bardy Diagnostics, Inc. Electrocardiography monitor configured for self-optimizing ECG data compression
US10888239B2 (en) 2013-09-25 2021-01-12 Bardy Diagnostics, Inc. Remote interfacing electrocardiography patch
US11096579B2 (en) 2019-07-03 2021-08-24 Bardy Diagnostics, Inc. System and method for remote ECG data streaming in real-time
US11116451B2 (en) 2019-07-03 2021-09-14 Bardy Diagnostics, Inc. Subcutaneous P-wave centric insertable cardiac monitor with energy harvesting capabilities
US11213237B2 (en) 2013-09-25 2022-01-04 Bardy Diagnostics, Inc. System and method for secure cloud-based physiological data processing and delivery
US11324441B2 (en) 2013-09-25 2022-05-10 Bardy Diagnostics, Inc. Electrocardiography and respiratory monitor
US11678830B2 (en) 2017-12-05 2023-06-20 Bardy Diagnostics, Inc. Noise-separating cardiac monitor
US11696681B2 (en) 2019-07-03 2023-07-11 Bardy Diagnostics Inc. Configurable hardware platform for physiological monitoring of a living body
US11723575B2 (en) 2013-09-25 2023-08-15 Bardy Diagnostics, Inc. Electrocardiography patch

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003026735A2 (en) 2001-09-28 2003-04-03 Meagan Medical, Inc. Method and apparatus for controlling percutaneous electrical signals
EP1432472A2 (en) * 2001-09-28 2004-06-30 Vertis Neuroscience, Inc. Method and apparatus for securing and/or identifying a link to a percutaneous probe
EP1618920A3 (en) * 2002-12-16 2007-05-30 Meagan Medical, Inc. Controlling the depth of percuataneous applications
JP2006509605A (en) * 2002-12-16 2006-03-23 メーガン メディカル アイエヌシー Percutaneous device with electrical coupling
EP1578485A4 (en) * 2002-12-16 2006-04-05 Meagan Medical Inc Coupling percutaneous devices to a patient
US7840272B2 (en) 2005-06-03 2010-11-23 Medrelief Inc. Methods for modulating osteochondral development using bioelectrical stimulation
GB0605807D0 (en) * 2006-03-23 2006-05-03 Depuy Int Ltd A template for use in a surgical procedure
US20090048504A1 (en) * 2007-08-17 2009-02-19 Biofisica Inc. Medical electrode systems and methods
DK2231231T3 (en) * 2007-12-10 2019-05-06 Medtronic Minimed Inc INTRODUCTION SYSTEM AND INSTALLATION DEVICE
US8433386B2 (en) * 2009-11-02 2013-04-30 Xialing Zhang Subdermal needle electrode cable assembly having movable needle safety cover integral therewith
AU2012211041A1 (en) * 2011-01-28 2013-08-15 Kambouris Shares Pty Ltd An electrode for subcutaneous electolipolysis
US8750956B2 (en) * 2011-09-21 2014-06-10 Edward Allen Riess Method and devices for its employ for reducing disease-transfer risks
US10154922B1 (en) * 2015-02-24 2018-12-18 Elira, Inc. Systems and methods for enabling appetite modulation and/or improving dietary compliance using percutaneous electrical neurostimulation
US10932683B2 (en) 2015-10-12 2021-03-02 Musc Foundation For Research Development Needle electrode fixation device and associated methods
US10624548B2 (en) * 2016-09-09 2020-04-21 Rhythmlink International, Llc Electrode assembly with thread electrode
US11241573B2 (en) * 2017-11-16 2022-02-08 Ebt Medical, Inc. Percutaneous and transcutaneous peripheral neuromodulation

Citations (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3030959A (en) * 1959-09-04 1962-04-24 Praemeta Surgical lancet for blood sampling
US3090151A (en) * 1958-02-14 1963-05-21 Stewart Trigg Underwater spear gun
US3208452A (en) * 1960-09-08 1965-09-28 Panray Parlam Corp Surface treating device
US3938526A (en) * 1974-05-20 1976-02-17 Anderson Weston A Electrical acupuncture needle heater
US3943935A (en) * 1973-09-07 1976-03-16 Cameron Robert C Disposable earlobe piercing apparatus
US3983881A (en) * 1975-05-21 1976-10-05 Telectronics Pty. Limited Muscle stimulator
US4139011A (en) * 1975-12-19 1979-02-13 Benoit Jean L P M Device for driving a needle into a patient
US4153059A (en) * 1977-10-25 1979-05-08 Minnesota Mining And Manufacturing Company Urinary incontinence stimulator system
US4207903A (en) * 1978-04-28 1980-06-17 Medtronic, Inc. Device for screwing body tissue electrode into body tissue
US4256116A (en) * 1978-07-03 1981-03-17 Technion Research And Development Foundation, Limited Transcutaneous pain reliever
US4262672A (en) * 1978-01-02 1981-04-21 Horst Kief Acupuncture instrument
US4281659A (en) * 1979-03-12 1981-08-04 Roche Medical Electronics Inc. Applying and securing percutaneous or transcutaneous probes to the skin especially for fetal monitoring
US4284856A (en) * 1979-09-24 1981-08-18 Hochmair Ingeborg Multi-frequency system and method for enhancing auditory stimulation and the like
US4381012A (en) * 1980-09-24 1983-04-26 Wallant International Trade, Inc. Electrode placement device
US4408617A (en) * 1980-01-21 1983-10-11 Deloffre Auguste Apparatus for detecting the acupuncture points on a patient and for applying electrical stimulating signals to the detected points
US4431000A (en) * 1978-11-29 1984-02-14 Gatron Corporation Transcutaneous nerve stimulator with pseusorandom pulse generator
US4437467A (en) * 1981-12-11 1984-03-20 American Home Products Corporation Apparatus for monitoring fetal heartbeat and the like
US4512351A (en) * 1982-11-19 1985-04-23 Cordis Corporation Percutaneous lead introducing system and method
US4541432A (en) * 1982-12-08 1985-09-17 Neurotronic Ltee Electric nerve stimulator device
US4556064A (en) * 1983-01-25 1985-12-03 Bruce Pomeranz Electrotherapy acupuncture apparatus and method
US4583549A (en) * 1984-05-30 1986-04-22 Samir Manoli ECG electrode pad
US4685466A (en) * 1985-01-29 1987-08-11 Rau Guenter Measuring sensor for the non-invasive detection of electro-physiological quantities
US4686996A (en) * 1985-12-24 1987-08-18 Paul Ulbrich Electrode assembly for sensing heart activity
US4712558A (en) * 1984-03-13 1987-12-15 Bio Medical Research Ltd. Electrical stimulation of muscle
USD297047S (en) * 1986-12-01 1988-08-02 Hon Edward H Sensor support plate for use with an external medical monitor device
US4765310A (en) * 1985-11-01 1988-08-23 Dynatens Research Corporation Electrical and magnetic pain treatment device
US4895154A (en) * 1988-02-19 1990-01-23 Staodynamics, Inc. Electronic stimulating device for enhanced healing of soft tissue wounds
US4934371A (en) * 1988-02-09 1990-06-19 American Home Products Corporation Fetal electrode product
US4949734A (en) * 1988-08-25 1990-08-21 Gerald Bernstein Shield for electrosurgical device
US4953564A (en) * 1989-08-23 1990-09-04 Medtronic, Inc. Screw-in drug eluting lead
US4979508A (en) * 1984-10-09 1990-12-25 Beck Stephen C Apparatus for generating phosphenes
US5012811A (en) * 1988-02-09 1991-05-07 American Home Products Corporation Fetal electrode product with protective cap
USD318330S (en) * 1987-10-15 1991-07-16 Doty James R Unipolar spiral coil electrode for monitoring the electrical activity of the brain
US5033474A (en) * 1990-01-05 1991-07-23 Buddy Systems, Inc. ECG cable storage means in a personal health monitor
US5036850A (en) * 1989-08-25 1991-08-06 Staodyn, Inc. Biphasic pulse output stage for electronic stimulating device
US5054486A (en) * 1990-05-31 1991-10-08 Mamoru Yamada Remedial techniques for the treatment of painful disorders such as intervertebral disc hernia and the like
US5094242A (en) * 1988-11-07 1992-03-10 Regents Of The University Of California Implantable nerve stimulation device
US5117826A (en) * 1987-02-02 1992-06-02 Staodyn, Inc. Combined nerve fiber and body tissue stimulation apparatus and method
US5211175A (en) * 1988-11-07 1993-05-18 Regents Of The University Of California Method for implanting electra-acupuncture needle
US5246014A (en) * 1991-11-08 1993-09-21 Medtronic, Inc. Implantable lead system
US5255691A (en) * 1991-11-13 1993-10-26 Medtronic, Inc. Percutaneous epidural lead introducing system and method
US5269304A (en) * 1989-03-04 1993-12-14 Tony Matthews Electro-therapy apparatus
US5281218A (en) * 1992-06-05 1994-01-25 Cardiac Pathways Corporation Catheter having needle electrode for radiofrequency ablation
US5332401A (en) * 1989-11-01 1994-07-26 Capel Ifor Donald Apparatus and method for transcranial electrotheraphy
USD357069S (en) * 1993-08-25 1995-04-04 Quinton Instrument Company Medical electrode
US5417719A (en) * 1993-08-25 1995-05-23 Medtronic, Inc. Method of using a spinal cord stimulation lead
US5423314A (en) * 1992-08-26 1995-06-13 Hewlett Packard Company Introduction apparatus for a fetal scalp electrode
US5439440A (en) * 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US5449378A (en) * 1992-05-08 1995-09-12 Schouenborg; Jens Method and apparatus for the electric stimulation of skin receptors
US5593429A (en) * 1994-06-28 1997-01-14 Cadwell Industries, Inc. Needle electrode with depth of penetration limiter
US5649936A (en) * 1995-09-19 1997-07-22 Real; Douglas D. Stereotactic guide apparatus for use with neurosurgical headframe
US5674267A (en) * 1993-03-30 1997-10-07 Centre National De La Recherche Scientifique Electric pulse applicator using pairs of needle electrodes for the treatment of biological tissue
US5682233A (en) * 1995-09-08 1997-10-28 Integ, Inc. Interstitial fluid sampler
US5702359A (en) * 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US5810762A (en) * 1995-04-10 1998-09-22 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US5851223A (en) * 1991-05-21 1998-12-22 Medi Consultants, Inc. Combination non-intrusive analgesic neuroaugmentive system and method triple-modulated gigatens with optional bipolar spike
US5861015A (en) * 1997-05-05 1999-01-19 Benja-Athon; Anuthep Modulation of the nervous system for treatment of pain and related disorders
US5873849A (en) * 1997-04-24 1999-02-23 Ichor Medical Systems, Inc. Electrodes and electrode arrays for generating electroporation inducing electrical fields
US5941845A (en) * 1997-08-05 1999-08-24 Irvine Biomedical, Inc. Catheter having multiple-needle electrode and methods thereof
US5948008A (en) * 1995-12-28 1999-09-07 S.L.T. Japan Co., Ltd. Apparatus for treatment of lumbar disc herniation
US5968063A (en) * 1997-05-14 1999-10-19 Jennifer Chu Intramuscular stimulation therapy facilitating device and method
US5968011A (en) * 1997-06-20 1999-10-19 Maersk Medical A/S Subcutaneous injection set
US6009347A (en) * 1998-01-27 1999-12-28 Genetronics, Inc. Electroporation apparatus with connective electrode template
US6032064A (en) * 1996-10-11 2000-02-29 Aspect Medical Systems, Inc. Electrode array system for measuring electrophysiological signals
US6035236A (en) * 1998-07-13 2000-03-07 Bionergy Therapeutics, Inc. Methods and apparatus for electrical microcurrent stimulation therapy
US6050992A (en) * 1997-05-19 2000-04-18 Radiotherapeutics Corporation Apparatus and method for treating tissue with multiple electrodes
US6068650A (en) * 1997-08-01 2000-05-30 Gentronics Inc. Method of Selectively applying needle array configurations
US6117077A (en) * 1999-01-22 2000-09-12 Del Mar Medical Systems, Llc Long-term, ambulatory physiological recorder
US6122547A (en) * 1998-10-20 2000-09-19 Benja-Athon; Anuthep Consolidated electrical-lead acupuncture needle
US6208893B1 (en) * 1998-01-27 2001-03-27 Genetronics, Inc. Electroporation apparatus with connective electrode template
US6219569B1 (en) * 1995-07-28 2001-04-17 Unilead International Inc. Electrodeless electro-dermal device
USD443063S1 (en) * 2000-08-25 2001-05-29 Nexan Limited Chest multisensor array
US6269270B1 (en) * 1998-10-26 2001-07-31 Birinder Bob Boveja Apparatus and method for adjunct (add-on) therapy of Dementia and Alzheimer's disease utilizing an implantable lead and external stimulator
US6304785B1 (en) * 1998-10-27 2001-10-16 Huntington Medical Research Institute Electrode insertion tool
US6341237B1 (en) * 1999-10-25 2002-01-22 Arthur F. Hurtado Device for administrating electro-muscle stimulation and method of use
US6355021B1 (en) * 1998-07-14 2002-03-12 Maersk Medical A/S Medical puncturing device
US6493592B1 (en) * 1999-12-01 2002-12-10 Vertis Neuroscience, Inc. Percutaneous electrical therapy system with electrode position maintenance
US6516226B1 (en) * 1999-12-01 2003-02-04 Vertis Neuroscience, Inc. Percutaneous electrical therapy system for minimizing electrode insertion discomfort
US6539264B1 (en) * 1999-12-01 2003-03-25 Vertis Neuroscience, Inc. Percutaneous electrical therapy system with sharp point protection
US6549810B1 (en) * 1999-12-01 2003-04-15 Vertis Neuroscience, Inc. Percutaneous electrical therapy system with electrode depth control
US6549797B1 (en) * 1999-12-01 2003-04-15 Vertis Neuroscience, Inc. Electrode remover for a percutaneous electrical therapy system
US6552927B2 (en) * 2001-01-30 2003-04-22 Motorola, Inc. MRAM architecture and system
US6556869B1 (en) * 1999-12-01 2003-04-29 Vertis Neuroscience, Inc. Electrode introducer for a percutaneous electrical therapy system
US6560491B1 (en) * 1999-12-01 2003-05-06 Vertis Neuroscience, Inc. Percutaneous electrical therapy system providing electrode axial support

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2500309A3 (en) 1981-02-25 1982-08-27 Faiveley Sa Electrical pulse generator producing analgesic effect - applies short rise time pulses, which are amplitude modulated and passed through wobbulator to affect human tissues
FR2500745B1 (en) 1981-03-02 1986-07-04 Dervieux Dominique DETECTION AND STIMULATION APPARATUS FOR ACUPUNCTURE TREATMENT
FR2567762B1 (en) 1984-07-20 1989-04-14 Simonin Philippe DEVICE FOR THE AESTHETIC TREATMENT OF THE SKIN
GB8729447D0 (en) * 1987-12-17 1988-02-03 Shell Int Research Colloidal polymer dispersion for internal sealing of pipes & process for application thereof
US6529776B1 (en) 1999-12-01 2003-03-04 Vertis Neuroscience, Inc. Method and apparatus for repositioning a percutaneous probe
US6522927B1 (en) 1999-12-01 2003-02-18 Vertis Neuroscience, Inc. Electrode assembly for a percutaneous electrical therapy system

Patent Citations (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3090151A (en) * 1958-02-14 1963-05-21 Stewart Trigg Underwater spear gun
US3030959A (en) * 1959-09-04 1962-04-24 Praemeta Surgical lancet for blood sampling
US3208452A (en) * 1960-09-08 1965-09-28 Panray Parlam Corp Surface treating device
US3943935A (en) * 1973-09-07 1976-03-16 Cameron Robert C Disposable earlobe piercing apparatus
US3938526A (en) * 1974-05-20 1976-02-17 Anderson Weston A Electrical acupuncture needle heater
US3983881A (en) * 1975-05-21 1976-10-05 Telectronics Pty. Limited Muscle stimulator
US4139011A (en) * 1975-12-19 1979-02-13 Benoit Jean L P M Device for driving a needle into a patient
US4153059A (en) * 1977-10-25 1979-05-08 Minnesota Mining And Manufacturing Company Urinary incontinence stimulator system
US4262672A (en) * 1978-01-02 1981-04-21 Horst Kief Acupuncture instrument
US4207903A (en) * 1978-04-28 1980-06-17 Medtronic, Inc. Device for screwing body tissue electrode into body tissue
US4256116A (en) * 1978-07-03 1981-03-17 Technion Research And Development Foundation, Limited Transcutaneous pain reliever
US4431000A (en) * 1978-11-29 1984-02-14 Gatron Corporation Transcutaneous nerve stimulator with pseusorandom pulse generator
US4281659A (en) * 1979-03-12 1981-08-04 Roche Medical Electronics Inc. Applying and securing percutaneous or transcutaneous probes to the skin especially for fetal monitoring
US4284856A (en) * 1979-09-24 1981-08-18 Hochmair Ingeborg Multi-frequency system and method for enhancing auditory stimulation and the like
US4408617A (en) * 1980-01-21 1983-10-11 Deloffre Auguste Apparatus for detecting the acupuncture points on a patient and for applying electrical stimulating signals to the detected points
US4381012A (en) * 1980-09-24 1983-04-26 Wallant International Trade, Inc. Electrode placement device
US4437467A (en) * 1981-12-11 1984-03-20 American Home Products Corporation Apparatus for monitoring fetal heartbeat and the like
US4512351A (en) * 1982-11-19 1985-04-23 Cordis Corporation Percutaneous lead introducing system and method
US4541432A (en) * 1982-12-08 1985-09-17 Neurotronic Ltee Electric nerve stimulator device
US4556064A (en) * 1983-01-25 1985-12-03 Bruce Pomeranz Electrotherapy acupuncture apparatus and method
US4712558A (en) * 1984-03-13 1987-12-15 Bio Medical Research Ltd. Electrical stimulation of muscle
US4583549A (en) * 1984-05-30 1986-04-22 Samir Manoli ECG electrode pad
US4979508A (en) * 1984-10-09 1990-12-25 Beck Stephen C Apparatus for generating phosphenes
US4685466A (en) * 1985-01-29 1987-08-11 Rau Guenter Measuring sensor for the non-invasive detection of electro-physiological quantities
US4765310A (en) * 1985-11-01 1988-08-23 Dynatens Research Corporation Electrical and magnetic pain treatment device
US4686996A (en) * 1985-12-24 1987-08-18 Paul Ulbrich Electrode assembly for sensing heart activity
USD297047S (en) * 1986-12-01 1988-08-02 Hon Edward H Sensor support plate for use with an external medical monitor device
US5117826A (en) * 1987-02-02 1992-06-02 Staodyn, Inc. Combined nerve fiber and body tissue stimulation apparatus and method
USD318330S (en) * 1987-10-15 1991-07-16 Doty James R Unipolar spiral coil electrode for monitoring the electrical activity of the brain
US4934371A (en) * 1988-02-09 1990-06-19 American Home Products Corporation Fetal electrode product
US5012811A (en) * 1988-02-09 1991-05-07 American Home Products Corporation Fetal electrode product with protective cap
US4895154A (en) * 1988-02-19 1990-01-23 Staodynamics, Inc. Electronic stimulating device for enhanced healing of soft tissue wounds
US4949734A (en) * 1988-08-25 1990-08-21 Gerald Bernstein Shield for electrosurgical device
US5211175A (en) * 1988-11-07 1993-05-18 Regents Of The University Of California Method for implanting electra-acupuncture needle
US5094242A (en) * 1988-11-07 1992-03-10 Regents Of The University Of California Implantable nerve stimulation device
US5269304A (en) * 1989-03-04 1993-12-14 Tony Matthews Electro-therapy apparatus
US4953564A (en) * 1989-08-23 1990-09-04 Medtronic, Inc. Screw-in drug eluting lead
US5036850A (en) * 1989-08-25 1991-08-06 Staodyn, Inc. Biphasic pulse output stage for electronic stimulating device
US5332401A (en) * 1989-11-01 1994-07-26 Capel Ifor Donald Apparatus and method for transcranial electrotheraphy
US5033474A (en) * 1990-01-05 1991-07-23 Buddy Systems, Inc. ECG cable storage means in a personal health monitor
US5054486A (en) * 1990-05-31 1991-10-08 Mamoru Yamada Remedial techniques for the treatment of painful disorders such as intervertebral disc hernia and the like
US5851223A (en) * 1991-05-21 1998-12-22 Medi Consultants, Inc. Combination non-intrusive analgesic neuroaugmentive system and method triple-modulated gigatens with optional bipolar spike
US5246014A (en) * 1991-11-08 1993-09-21 Medtronic, Inc. Implantable lead system
US5255691A (en) * 1991-11-13 1993-10-26 Medtronic, Inc. Percutaneous epidural lead introducing system and method
US5449378A (en) * 1992-05-08 1995-09-12 Schouenborg; Jens Method and apparatus for the electric stimulation of skin receptors
US5281218A (en) * 1992-06-05 1994-01-25 Cardiac Pathways Corporation Catheter having needle electrode for radiofrequency ablation
US5423314A (en) * 1992-08-26 1995-06-13 Hewlett Packard Company Introduction apparatus for a fetal scalp electrode
US5674267A (en) * 1993-03-30 1997-10-07 Centre National De La Recherche Scientifique Electric pulse applicator using pairs of needle electrodes for the treatment of biological tissue
US5439440A (en) * 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
USD357069S (en) * 1993-08-25 1995-04-04 Quinton Instrument Company Medical electrode
US5417719A (en) * 1993-08-25 1995-05-23 Medtronic, Inc. Method of using a spinal cord stimulation lead
US5593429A (en) * 1994-06-28 1997-01-14 Cadwell Industries, Inc. Needle electrode with depth of penetration limiter
US5810762A (en) * 1995-04-10 1998-09-22 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US5702359A (en) * 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US6219569B1 (en) * 1995-07-28 2001-04-17 Unilead International Inc. Electrodeless electro-dermal device
US5682233A (en) * 1995-09-08 1997-10-28 Integ, Inc. Interstitial fluid sampler
US5649936A (en) * 1995-09-19 1997-07-22 Real; Douglas D. Stereotactic guide apparatus for use with neurosurgical headframe
US5928144A (en) * 1995-09-19 1999-07-27 Real; Douglas D. Needle electrode
US5948008A (en) * 1995-12-28 1999-09-07 S.L.T. Japan Co., Ltd. Apparatus for treatment of lumbar disc herniation
US6032064A (en) * 1996-10-11 2000-02-29 Aspect Medical Systems, Inc. Electrode array system for measuring electrophysiological signals
US5873849A (en) * 1997-04-24 1999-02-23 Ichor Medical Systems, Inc. Electrodes and electrode arrays for generating electroporation inducing electrical fields
US5861015A (en) * 1997-05-05 1999-01-19 Benja-Athon; Anuthep Modulation of the nervous system for treatment of pain and related disorders
US5968063A (en) * 1997-05-14 1999-10-19 Jennifer Chu Intramuscular stimulation therapy facilitating device and method
US6050992A (en) * 1997-05-19 2000-04-18 Radiotherapeutics Corporation Apparatus and method for treating tissue with multiple electrodes
US5968011A (en) * 1997-06-20 1999-10-19 Maersk Medical A/S Subcutaneous injection set
US6068650A (en) * 1997-08-01 2000-05-30 Gentronics Inc. Method of Selectively applying needle array configurations
US5941845A (en) * 1997-08-05 1999-08-24 Irvine Biomedical, Inc. Catheter having multiple-needle electrode and methods thereof
US6009347A (en) * 1998-01-27 1999-12-28 Genetronics, Inc. Electroporation apparatus with connective electrode template
US6208893B1 (en) * 1998-01-27 2001-03-27 Genetronics, Inc. Electroporation apparatus with connective electrode template
US6035236A (en) * 1998-07-13 2000-03-07 Bionergy Therapeutics, Inc. Methods and apparatus for electrical microcurrent stimulation therapy
US6355021B1 (en) * 1998-07-14 2002-03-12 Maersk Medical A/S Medical puncturing device
US6122547A (en) * 1998-10-20 2000-09-19 Benja-Athon; Anuthep Consolidated electrical-lead acupuncture needle
US6269270B1 (en) * 1998-10-26 2001-07-31 Birinder Bob Boveja Apparatus and method for adjunct (add-on) therapy of Dementia and Alzheimer's disease utilizing an implantable lead and external stimulator
US6304785B1 (en) * 1998-10-27 2001-10-16 Huntington Medical Research Institute Electrode insertion tool
US6117077A (en) * 1999-01-22 2000-09-12 Del Mar Medical Systems, Llc Long-term, ambulatory physiological recorder
US6341237B1 (en) * 1999-10-25 2002-01-22 Arthur F. Hurtado Device for administrating electro-muscle stimulation and method of use
US6493592B1 (en) * 1999-12-01 2002-12-10 Vertis Neuroscience, Inc. Percutaneous electrical therapy system with electrode position maintenance
US6516226B1 (en) * 1999-12-01 2003-02-04 Vertis Neuroscience, Inc. Percutaneous electrical therapy system for minimizing electrode insertion discomfort
US6539264B1 (en) * 1999-12-01 2003-03-25 Vertis Neuroscience, Inc. Percutaneous electrical therapy system with sharp point protection
US6549810B1 (en) * 1999-12-01 2003-04-15 Vertis Neuroscience, Inc. Percutaneous electrical therapy system with electrode depth control
US6549797B1 (en) * 1999-12-01 2003-04-15 Vertis Neuroscience, Inc. Electrode remover for a percutaneous electrical therapy system
US6556869B1 (en) * 1999-12-01 2003-04-29 Vertis Neuroscience, Inc. Electrode introducer for a percutaneous electrical therapy system
US6560491B1 (en) * 1999-12-01 2003-05-06 Vertis Neuroscience, Inc. Percutaneous electrical therapy system providing electrode axial support
USD443063S1 (en) * 2000-08-25 2001-05-29 Nexan Limited Chest multisensor array
US6552927B2 (en) * 2001-01-30 2003-04-22 Motorola, Inc. MRAM architecture and system

Cited By (136)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8613709B2 (en) 2010-10-08 2013-12-24 Cardiac Science Corporation Ambulatory electrocardiographic monitor for providing ease of use in women
US8626277B2 (en) 2010-10-08 2014-01-07 Cardiac Science Corporation Computer-implemented electrocardiographic data processor with time stamp correlation
US8613708B2 (en) 2010-10-08 2013-12-24 Cardiac Science Corporation Ambulatory electrocardiographic monitor with jumpered sensing electrode
US8938287B2 (en) 2010-10-08 2015-01-20 Cardiac Science Corporation Computer-implemented electrocardiograhic data processor with time stamp correlation
US9037477B2 (en) 2010-10-08 2015-05-19 Cardiac Science Corporation Computer-implemented system and method for evaluating ambulatory electrocardiographic monitoring of cardiac rhythm disorders
CN105556602A (en) * 2013-08-29 2016-05-04 杜比国际公司 Frequency band table design for high frequency reconstruction algorithms
US11272872B2 (en) 2013-09-25 2022-03-15 Bardy Diagnostics, Inc. Expended wear ambulatory electrocardiography and physiological sensor monitor
US11445907B2 (en) 2013-09-25 2022-09-20 Bardy Diagnostics, Inc. Ambulatory encoding monitor recorder optimized for rescalable encoding and method of use
US11918364B2 (en) 2013-09-25 2024-03-05 Bardy Diagnostics, Inc. Extended wear ambulatory electrocardiography and physiological sensor monitor
US9345414B1 (en) 2013-09-25 2016-05-24 Bardy Diagnostics, Inc. Method for providing dynamic gain over electrocardiographic data with the aid of a digital computer
US9364155B2 (en) 2013-09-25 2016-06-14 Bardy Diagnostics, Inc. Self-contained personal air flow sensing monitor
US11826151B2 (en) 2013-09-25 2023-11-28 Bardy Diagnostics, Inc. System and method for physiological data classification for use in facilitating diagnosis
US9408545B2 (en) 2013-09-25 2016-08-09 Bardy Diagnostics, Inc. Method for efficiently encoding and compressing ECG data optimized for use in an ambulatory ECG monitor
US9433380B1 (en) 2013-09-25 2016-09-06 Bardy Diagnostics, Inc. Extended wear electrocardiography patch
US9433367B2 (en) 2013-09-25 2016-09-06 Bardy Diagnostics, Inc. Remote interfacing of extended wear electrocardiography and physiological sensor monitor
US11793441B2 (en) 2013-09-25 2023-10-24 Bardy Diagnostics, Inc. Electrocardiography patch
US11786159B2 (en) 2013-09-25 2023-10-17 Bardy Diagnostics, Inc. Self-authenticating electrocardiography and physiological sensor monitor
US9545228B2 (en) 2013-09-25 2017-01-17 Bardy Diagnostics, Inc. Extended wear electrocardiography and respiration-monitoring patch
US9545204B2 (en) 2013-09-25 2017-01-17 Bardy Diagnostics, Inc. Extended wear electrocardiography patch
US9554715B2 (en) 2013-09-25 2017-01-31 Bardy Diagnostics, Inc. System and method for electrocardiographic data signal gain determination with the aid of a digital computer
US9615763B2 (en) 2013-09-25 2017-04-11 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitor recorder optimized for capturing low amplitude cardiac action potential propagation
US9619660B1 (en) 2013-09-25 2017-04-11 Bardy Diagnostics, Inc. Computer-implemented system for secure physiological data collection and processing
US9642537B2 (en) 2013-09-25 2017-05-09 Bardy Diagnostics, Inc. Ambulatory extended-wear electrocardiography and syncope sensor monitor
US9655538B2 (en) 2013-09-25 2017-05-23 Bardy Diagnostics, Inc. Self-authenticating electrocardiography monitoring circuit
US9655537B2 (en) 2013-09-25 2017-05-23 Bardy Diagnostics, Inc. Wearable electrocardiography and physiology monitoring ensemble
US9700227B2 (en) 2013-09-25 2017-07-11 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation
US11744513B2 (en) 2013-09-25 2023-09-05 Bardy Diagnostics, Inc. Electrocardiography and respiratory monitor
US9717433B2 (en) 2013-09-25 2017-08-01 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation
US9717432B2 (en) 2013-09-25 2017-08-01 Bardy Diagnostics, Inc. Extended wear electrocardiography patch using interlaced wire electrodes
US9730593B2 (en) 2013-09-25 2017-08-15 Bardy Diagnostics, Inc. Extended wear ambulatory electrocardiography and physiological sensor monitor
US9730641B2 (en) 2013-09-25 2017-08-15 Bardy Diagnostics, Inc. Monitor recorder-implemented method for electrocardiography value encoding and compression
US10499812B2 (en) 2013-09-25 2019-12-10 Bardy Diagnostics, Inc. System and method for applying a uniform dynamic gain over cardiac data with the aid of a digital computer
US9737224B2 (en) 2013-09-25 2017-08-22 Bardy Diagnostics, Inc. Event alerting through actigraphy embedded within electrocardiographic data
US9775536B2 (en) 2013-09-25 2017-10-03 Bardy Diagnostics, Inc. Method for constructing a stress-pliant physiological electrode assembly
US11723575B2 (en) 2013-09-25 2023-08-15 Bardy Diagnostics, Inc. Electrocardiography patch
US11701045B2 (en) 2013-09-25 2023-07-18 Bardy Diagnostics, Inc. Expended wear ambulatory electrocardiography monitor
US11701044B2 (en) 2013-09-25 2023-07-18 Bardy Diagnostics, Inc. Electrocardiography patch
US9820665B2 (en) 2013-09-25 2017-11-21 Bardy Diagnostics, Inc. Remote interfacing of extended wear electrocardiography and physiological sensor monitor
US9901274B2 (en) 2013-09-25 2018-02-27 Bardy Diagnostics, Inc. Electrocardiography patch
US11678799B2 (en) 2013-09-25 2023-06-20 Bardy Diagnostics, Inc. Subcutaneous electrocardiography monitor configured for test-based data compression
US9955888B2 (en) 2013-09-25 2018-05-01 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitor recorder optimized for internal signal processing
US9955911B2 (en) 2013-09-25 2018-05-01 Bardy Diagnostics, Inc. Electrocardiography and respiratory monitor recorder
US9955885B2 (en) 2013-09-25 2018-05-01 Bardy Diagnostics, Inc. System and method for physiological data processing and delivery
US10004415B2 (en) 2013-09-25 2018-06-26 Bardy Diagnostics, Inc. Extended wear electrocardiography patch
US10045709B2 (en) 2013-09-25 2018-08-14 Bardy Diagnostics, Inc. System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer
US10052022B2 (en) 2013-09-25 2018-08-21 Bardy Diagnostics, Inc. System and method for providing dynamic gain over non-noise electrocardiographic data with the aid of a digital computer
US10561328B2 (en) 2013-09-25 2020-02-18 Bardy Diagnostics, Inc. Multipart electrocardiography monitor optimized for capturing low amplitude cardiac action potential propagation
US10478083B2 (en) 2013-09-25 2019-11-19 Bardy Diagnostics, Inc. Extended wear ambulatory electrocardiography and physiological sensor monitor
US10111601B2 (en) 2013-09-25 2018-10-30 Bardy Diagnostics, Inc. Extended wear electrocardiography monitor optimized for capturing low amplitude cardiac action potential propagation
US11678832B2 (en) 2013-09-25 2023-06-20 Bardy Diagnostics, Inc. System and method for atrial fibrillation detection in non-noise ECG data with the aid of a digital computer
US10154793B2 (en) 2013-09-25 2018-12-18 Bardy Diagnostics, Inc. Extended wear electrocardiography patch with wire contact surfaces
US10165946B2 (en) 2013-09-25 2019-01-01 Bardy Diagnostics, Inc. Computer-implemented system and method for providing a personal mobile device-triggered medical intervention
US10172534B2 (en) 2013-09-25 2019-01-08 Bardy Diagnostics, Inc. Remote interfacing electrocardiography patch
US11660035B2 (en) 2013-09-25 2023-05-30 Bardy Diagnostics, Inc. Insertable cardiac monitor
US11660037B2 (en) 2013-09-25 2023-05-30 Bardy Diagnostics, Inc. System for electrocardiographic signal acquisition and processing
US10251576B2 (en) 2013-09-25 2019-04-09 Bardy Diagnostics, Inc. System and method for ECG data classification for use in facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer
US10251575B2 (en) 2013-09-25 2019-04-09 Bardy Diagnostics, Inc. Wearable electrocardiography and physiology monitoring ensemble
US10264992B2 (en) 2013-09-25 2019-04-23 Bardy Diagnostics, Inc. Extended wear sewn electrode electrocardiography monitor
US10265015B2 (en) 2013-09-25 2019-04-23 Bardy Diagnostics, Inc. Monitor recorder optimized for electrocardiography and respiratory data acquisition and processing
US10271756B2 (en) 2013-09-25 2019-04-30 Bardy Diagnostics, Inc. Monitor recorder optimized for electrocardiographic signal processing
US10271755B2 (en) 2013-09-25 2019-04-30 Bardy Diagnostics, Inc. Method for constructing physiological electrode assembly with sewn wire interconnects
US10278606B2 (en) 2013-09-25 2019-05-07 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitor optimized for capturing low amplitude cardiac action potential propagation
US10278603B2 (en) 2013-09-25 2019-05-07 Bardy Diagnostics, Inc. System and method for secure physiological data acquisition and storage
US11653868B2 (en) 2013-09-25 2023-05-23 Bardy Diagnostics, Inc. Subcutaneous insertable cardiac monitor optimized for electrocardiographic (ECG) signal acquisition
US10398334B2 (en) 2013-09-25 2019-09-03 Bardy Diagnostics, Inc. Self-authenticating electrocardiography monitoring circuit
US10413205B2 (en) 2013-09-25 2019-09-17 Bardy Diagnostics, Inc. Electrocardiography and actigraphy monitoring system
US10433743B1 (en) 2013-09-25 2019-10-08 Bardy Diagnostics, Inc. Method for secure physiological data acquisition and storage
US10433748B2 (en) 2013-09-25 2019-10-08 Bardy Diagnostics, Inc. Extended wear electrocardiography and physiological sensor monitor
US10433751B2 (en) 2013-09-25 2019-10-08 Bardy Diagnostics, Inc. System and method for facilitating a cardiac rhythm disorder diagnosis based on subcutaneous cardiac monitoring data
US10463269B2 (en) 2013-09-25 2019-11-05 Bardy Diagnostics, Inc. System and method for machine-learning-based atrial fibrillation detection
US11653870B2 (en) 2013-09-25 2023-05-23 Bardy Diagnostics, Inc. System and method for display of subcutaneous cardiac monitoring data
US9737211B2 (en) 2013-09-25 2017-08-22 Bardy Diagnostics, Inc. Ambulatory rescalable encoding monitor recorder
US11653869B2 (en) 2013-09-25 2023-05-23 Bardy Diagnostics, Inc. Multicomponent electrocardiography monitor
US10561326B2 (en) 2013-09-25 2020-02-18 Bardy Diagnostics, Inc. Monitor recorder optimized for electrocardiographic potential processing
US10602977B2 (en) 2013-09-25 2020-03-31 Bardy Diagnostics, Inc. Electrocardiography and respiratory monitor
US10624552B2 (en) 2013-09-25 2020-04-21 Bardy Diagnostics, Inc. Method for constructing physiological electrode assembly with integrated flexile wire components
US10624551B2 (en) 2013-09-25 2020-04-21 Bardy Diagnostics, Inc. Insertable cardiac monitor for use in performing long term electrocardiographic monitoring
US10631748B2 (en) 2013-09-25 2020-04-28 Bardy Diagnostics, Inc. Extended wear electrocardiography patch with wire interconnects
US10667711B1 (en) 2013-09-25 2020-06-02 Bardy Diagnostics, Inc. Contact-activated extended wear electrocardiography and physiological sensor monitor recorder
US10716516B2 (en) 2013-09-25 2020-07-21 Bardy Diagnostics, Inc. Monitor recorder-implemented method for electrocardiography data compression
US11647941B2 (en) 2013-09-25 2023-05-16 Bardy Diagnostics, Inc. System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer
US10736532B2 (en) 2013-09-25 2020-08-11 Bardy Diagnotics, Inc. System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer
US10736531B2 (en) 2013-09-25 2020-08-11 Bardy Diagnostics, Inc. Subcutaneous insertable cardiac monitor optimized for long term, low amplitude electrocardiographic data collection
US10736529B2 (en) 2013-09-25 2020-08-11 Bardy Diagnostics, Inc. Subcutaneous insertable electrocardiography monitor
US10799137B2 (en) 2013-09-25 2020-10-13 Bardy Diagnostics, Inc. System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer
US10806360B2 (en) 2013-09-25 2020-10-20 Bardy Diagnostics, Inc. Extended wear ambulatory electrocardiography and physiological sensor monitor
US10813568B2 (en) 2013-09-25 2020-10-27 Bardy Diagnostics, Inc. System and method for classifier-based atrial fibrillation detection with the aid of a digital computer
US10813567B2 (en) 2013-09-25 2020-10-27 Bardy Diagnostics, Inc. System and method for composite display of subcutaneous cardiac monitoring data
US10820801B2 (en) 2013-09-25 2020-11-03 Bardy Diagnostics, Inc. Electrocardiography monitor configured for self-optimizing ECG data compression
US10849523B2 (en) 2013-09-25 2020-12-01 Bardy Diagnostics, Inc. System and method for ECG data classification for use in facilitating diagnosis of cardiac rhythm disorders
US11647939B2 (en) 2013-09-25 2023-05-16 Bardy Diagnostics, Inc. System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer
US10888239B2 (en) 2013-09-25 2021-01-12 Bardy Diagnostics, Inc. Remote interfacing electrocardiography patch
US10939841B2 (en) 2013-09-25 2021-03-09 Bardy Diagnostics, Inc. Wearable electrocardiography and physiology monitoring ensemble
US11006883B2 (en) 2013-09-25 2021-05-18 Bardy Diagnostics, Inc. Extended wear electrocardiography and physiological sensor monitor
US11013446B2 (en) 2013-09-25 2021-05-25 Bardy Diagnostics, Inc. System for secure physiological data acquisition and delivery
US11051754B2 (en) 2013-09-25 2021-07-06 Bardy Diagnostics, Inc. Electrocardiography and respiratory monitor
US11051743B2 (en) 2013-09-25 2021-07-06 Bardy Diagnostics, Inc. Electrocardiography patch
US11457852B2 (en) 2013-09-25 2022-10-04 Bardy Diagnostics, Inc. Multipart electrocardiography monitor
US11103173B2 (en) 2013-09-25 2021-08-31 Bardy Diagnostics, Inc. Electrocardiography patch
US11445970B2 (en) 2013-09-25 2022-09-20 Bardy Diagnostics, Inc. System and method for neural-network-based atrial fibrillation detection with the aid of a digital computer
US11179087B2 (en) 2013-09-25 2021-11-23 Bardy Diagnostics, Inc. System for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer
US11213237B2 (en) 2013-09-25 2022-01-04 Bardy Diagnostics, Inc. System and method for secure cloud-based physiological data processing and delivery
US11445967B2 (en) 2013-09-25 2022-09-20 Bardy Diagnostics, Inc. Electrocardiography patch
US11324441B2 (en) 2013-09-25 2022-05-10 Bardy Diagnostics, Inc. Electrocardiography and respiratory monitor
US11445966B2 (en) 2013-09-25 2022-09-20 Bardy Diagnostics, Inc. Extended wear electrocardiography and physiological sensor monitor
US11445969B2 (en) 2013-09-25 2022-09-20 Bardy Diagnostics, Inc. System and method for event-centered display of subcutaneous cardiac monitoring data
US11445965B2 (en) 2013-09-25 2022-09-20 Bardy Diagnostics, Inc. Subcutaneous insertable cardiac monitor optimized for long-term electrocardiographic monitoring
US11445908B2 (en) 2013-09-25 2022-09-20 Bardy Diagnostics, Inc. Subcutaneous electrocardiography monitor configured for self-optimizing ECG data compression
US11445961B2 (en) 2013-09-25 2022-09-20 Bardy Diagnostics, Inc. Self-authenticating electrocardiography and physiological sensor monitor
US11445964B2 (en) 2013-09-25 2022-09-20 Bardy Diagnostics, Inc. System for electrocardiographic potentials processing and acquisition
US11445962B2 (en) 2013-09-25 2022-09-20 Bardy Diagnostics, Inc. Ambulatory electrocardiography monitor
USD831833S1 (en) 2013-11-07 2018-10-23 Bardy Diagnostics, Inc. Extended wear electrode patch
USD838370S1 (en) 2013-11-07 2019-01-15 Bardy Diagnostics, Inc. Electrocardiography monitor
USD717955S1 (en) 2013-11-07 2014-11-18 Bardy Diagnostics, Inc. Electrocardiography monitor
USD801528S1 (en) 2013-11-07 2017-10-31 Bardy Diagnostics, Inc. Electrocardiography monitor
USD744659S1 (en) 2013-11-07 2015-12-01 Bardy Diagnostics, Inc. Extended wear electrode patch
USD892340S1 (en) 2013-11-07 2020-08-04 Bardy Diagnostics, Inc. Extended wear electrode patch
US9408551B2 (en) 2013-11-14 2016-08-09 Bardy Diagnostics, Inc. System and method for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer
US9782200B2 (en) * 2014-02-09 2017-10-10 Payam Andalib Neuromonitoring needle-cartridge gun system
US10201373B2 (en) 2014-02-09 2019-02-12 Payam Andalib Cartridge for neuromonitoring needle-cartridge gun system
US20150223894A1 (en) * 2014-02-09 2015-08-13 John E Burbank Neuromonitoring needle-cartridge gun system
US10098663B2 (en) 2014-02-09 2018-10-16 John E Burbank Method for placement of neuromonitoring needles
USD793566S1 (en) 2015-09-10 2017-08-01 Bardy Diagnostics, Inc. Extended wear electrode patch
USD766447S1 (en) 2015-09-10 2016-09-13 Bardy Diagnostics, Inc. Extended wear electrode patch
US9788722B2 (en) 2015-10-05 2017-10-17 Bardy Diagnostics, Inc. Method for addressing medical conditions through a wearable health monitor with the aid of a digital computer
US9936875B2 (en) 2015-10-05 2018-04-10 Bardy Diagnostics, Inc. Health monitoring apparatus for initiating a treatment of a patient with the aid of a digital computer
US10390700B2 (en) 2015-10-05 2019-08-27 Bardy Diagnostics, Inc. Health monitoring apparatus for initiating a treatment of a patient based on physiological data with the aid of a digital computer
US9504423B1 (en) 2015-10-05 2016-11-29 Bardy Diagnostics, Inc. Method for addressing medical conditions through a wearable health monitor with the aid of a digital computer
US10869601B2 (en) 2015-10-05 2020-12-22 Bardy Diagnostics, Inc. System and method for patient medical care initiation based on physiological monitoring data with the aid of a digital computer
US10123703B2 (en) 2015-10-05 2018-11-13 Bardy Diagnostics, Inc. Health monitoring apparatus with wireless capabilities for initiating a patient treatment with the aid of a digital computer
US11678830B2 (en) 2017-12-05 2023-06-20 Bardy Diagnostics, Inc. Noise-separating cardiac monitor
US11696681B2 (en) 2019-07-03 2023-07-11 Bardy Diagnostics Inc. Configurable hardware platform for physiological monitoring of a living body
US11116451B2 (en) 2019-07-03 2021-09-14 Bardy Diagnostics, Inc. Subcutaneous P-wave centric insertable cardiac monitor with energy harvesting capabilities
US11653880B2 (en) 2019-07-03 2023-05-23 Bardy Diagnostics, Inc. System for cardiac monitoring with energy-harvesting-enhanced data transfer capabilities
US11678798B2 (en) 2019-07-03 2023-06-20 Bardy Diagnostics Inc. System and method for remote ECG data streaming in real-time
US11096579B2 (en) 2019-07-03 2021-08-24 Bardy Diagnostics, Inc. System and method for remote ECG data streaming in real-time

Also Published As

Publication number Publication date
US6912424B2 (en) 2005-06-28
US20010021869A1 (en) 2001-09-13

Similar Documents

Publication Publication Date Title
US6912424B2 (en) Apparatus and method for coupling therapeutic and/or monitoring equipment to a patient
US6493592B1 (en) Percutaneous electrical therapy system with electrode position maintenance
US6549810B1 (en) Percutaneous electrical therapy system with electrode depth control
US6522927B1 (en) Electrode assembly for a percutaneous electrical therapy system
US9364658B2 (en) Electrical stimulation leads with multiple anchoring units and methods of making and using
US10130806B2 (en) Systems and methods for making and using a temporary lead
EP1237619B1 (en) Percutaneous electrical therapy system and electrode
US7340309B2 (en) Method and apparatus for controlling the depth of percutaneous applications
US20170216604A1 (en) Systems and methods for making and using connector contact arrays for electrical stimulation systems
US20040172115A1 (en) Apparatuses and methods for coupling percutaneous devices to a patient, and associated methods of manufacture
US6539264B1 (en) Percutaneous electrical therapy system with sharp point protection
US6622051B1 (en) Percutaneous electrical therapy system with electrode entry angle control
US6556869B1 (en) Electrode introducer for a percutaneous electrical therapy system
US6516226B1 (en) Percutaneous electrical therapy system for minimizing electrode insertion discomfort
US6560491B1 (en) Percutaneous electrical therapy system providing electrode axial support
CA2510067A1 (en) Percutaneous apparatus with electrical coupling
EP1611922A2 (en) Percutaneous apparatus with electrical coupling
US11172959B2 (en) Long, flexible sheath and lead blank and systems and methods of making and using

Legal Events

Date Code Title Description
AS Assignment

Owner name: MEAGAN MEDICAL, INC., NEVADA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VERTIS NEUROSCIENCE, INC.;REEL/FRAME:016021/0172

Effective date: 20030520

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION